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Abstract 
 
Some proteins carry recognition motifs that allow them to be sorted into 
different compartments of the cell. In Gram-positive bacteria, proteins with the 
LPXTG sorting motif are localized to the cell surface where they are attached to 
peptidoglycan by a membrane bound cysteine protease called sortase. The work 
presented here entails a novel Gram-negative sorting mechanism that includes 
the rhombosortase protease and the C-terminal recognition motif, GlyGly-
CTERM. GlyGly-CTERM domains contain serines and glycines, followed by a 
stretch of hydrophobic and positively charged residues. The composition of this 
domain makes it an ideal candidate to span the membrane and serve as a 
possible substrate for rhombosortase, a rhomboid-like protease. Rhomboid 
proteases are intramembrane serine proteases that cleave substrates with a 
single transmembrane domain that contains helix-destabilizing residues. With 
this information, we postulated that rhombosortase cleaves and promotes cell 
surface association of GlyGly-CTERM containing proteins similar to sortase. In 
order to test this hypothesis, the GlyGly-CTERM containing protein Vibrio 
extracellular serine protease B (VesB) was utilized. VesB contains an N-terminal 
signal peptide, a protease domain that includes the propeptide and the catalytic 
triad, and a C-terminal domain with the GlyGly-CTERM extension. VesB is a 
trypsin-like serine protease that has an apparent preference for arginine and 
cleaves both peptides and intact proteins.  
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Using activity assays, western blotting, proteomic analysis and fluorescent 
microscopy, these studies showed that the type II secretion (T2S) system is 
responsible for outer membrane translocation of VesB, while rhombosortase 
promotes its surface retention by cleaving the GlyGly-CTERM domain and 
perhaps further modifying the newly generated C-terminus of VesB. It was 
demonstrated that native VesB in a rhombosortase mutant and VesB produced 
without its GlyGly-CTERM domain were inactive and no longer cell-associated. 
This latter finding suggests that removal of the N-terminal propeptide and thereby 
activation of VesB occurs on the cell surface. Taken together, rhombosortase 
cleaves and promotes cell surface retention of the GlyGly-CTERM domain 
containing protein, VesB, thereby highlighting a novel protein sorting mechanism 



























Secreted Proteins and the Life Cycle of Vibrio cholerae: 
 
The life-threatening diarrheal disease cholera is caused by the Gram-
negative curved bacillus Vibrio cholerae and is found in two different biological 
niches, as an environmental reservoir in brackish waters and as a human 
pathogen (Nelson et al, 2009; Sack et al, 2004). The persistence of an 
environmental reservoir is extremely important for the transmission of cholera. In 
areas where V. cholerae is endemic, such as South Asia, outbreaks occur 
seasonally due to environmental changes and an increase in the V. cholerae 
population (Huq et al, 1984). Isolated outbreaks can occur when clean water, 
sanitation and health infrastructures are failing, like in Zimbabwe in 2008, where 
cholera was responsible for over 4,000 deaths 
(http://www.redcross.org.au/files/Zimbabwe-Report.pdf). In addition, through 
human travel cholera can be carried anywhere in the world within hours, and if 
brought to areas that have experienced natural disasters, like the earthquake in 
Haiti in 2010, cholera can cause massive outbreaks (Grad & Waldor, 2013).   
In aquatic environments, V. cholerae is associated with phytoplankton, 
such as algae; zooplankton, including copepods or chironomid egg masses; and 
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are either free-living or exist as biofilms on chitinous particles (Vezzulli et al, 
2008). Environmental factors such as temperature, salinity and concentrations of 
organic matter in water supports plankton blooms (Huq et al, 1984). Plankton are 
not only believed to protect V. cholerae from environmental stresses, but also 
serves as a nutrient source for growth, as attachment to live copepods aids in 
multiplication of V. cholerae (Huq et al, 1984). Studies have shown that plankton 
blooms correlate with an increase in V. cholerae population, which can provide 
enough of an infectious dose to result in clinical cholera if ingested by a human 
host (Colwell, 1996; Huq et al, 1984).  
In both the environment and in the host, the secretion and function of 
multiple proteins from V. cholerae are necessary for its survival and 
pathogenesis (Nelson et al, 2009). Some of these proteins play roles in both 
environments (Figure 1.1). Chitin binding protein (GbpA) is involved in the 
attachment of V. cholerae to zooplankton (Kirn et al, 2005). Hemagglutinin 
protease (HapA) has been shown to degrade the gelatinous matrix of chironomid 
egg masses, possibly providing a nutrient source to V. cholerae (Halpern et al, 
2003). Chitinase (ChiA) is responsible for degradation of chitinous material for V. 
cholerae to use as a carbon source (Connell et al, 1998). RbmC and Xds 
maintain the structure of biofilms in laboratory settings, a finding that can likely be 
extrapolated to biofilms in the environment (Fong & Yildiz, 2007; Seper et al, 
2011).
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Once V. cholerae enters the human host through consumption of 
contaminated food or water, it travels to the upper small intestine to colonize 
epithelial cells (Sack et al, 2004). Again, several secreted proteins help with the 
progression of disease and continuation of the life cycle. GbpA binds to mucin on 
intestinal epithelial cells, which enhances attachment of V. cholerae (Bhowmick 
et al, 2008; Kirn et al, 2005). In vitro studies suggest that neuraminidase 
increases the uptake of cholera toxin (CT), a major virulence factor and member 
of the AB5 toxin family, by cleaving complex gangliosides into GM1, the receptor 
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Figure 1.1: The life cycle of V. cholerae and the necessary secreted 
proteins. 
This diagram depicts the life cycle of V. cholerae, which shuttles between the 
environment and human host. The known secreted substrates are labeled on the 
figure based on where they play a role in their respective reservoirs.  
 
 
The B subunit of CT is able to bind to the exposed GM1 receptor and 
subsequently induce endocytosis of the A subunit. Before endocytosis, the A 
subunit is cleaved or “nicked” at Arg192 by either host intestinal proteases or 
Vibrio proteases, like HapA or Vibrio extracellular serine protease A and B (VesA 
and VesB) (Booth et al, 1984; Lencer et al, 1997; Sikora et al, 2011). The 
activated A subunit catalyzes ADP ribosylation of the G-protein complex leading 
to activation of adenylate cyclase and increased levels of cyclic-AMP. This 
causes rapid efflux of electrolytes and water into the intestinal lumen, which 
results in watery diarrhea (Nelson et al, 2009; Spangler, 1992). If water and 
electrolytes are not replenished in patients, they can die within hours (Sack et al, 
2004). To complete the life cycle, HapA is suggested to play a role in 
dissemination by aiding in the detachment of V. cholerae from intestinal epithelial 
cells (Finkelstein et al, 1992). In these cases, patients can shed up to 1012 
hyperinfectious vibrios per liter and this can be subsequently transmitted to the 
environment and other human hosts (Nelson et al, 2009).  
 
Type II Secretion (T2S) System: 
Several different secretion systems exist in Gram-negative bacteria to 
translocate proteins, however, all of the secreted factors mentioned above utilize 
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the T2S system to gain access to the extracellular milieu (Connell et al, 1998; 
Finkelstein et al, 1992; Gerlach & Hensel, 2007; Halpern et al, 2003; Kirn et al, 
2005; Overbye et al, 1993; Sandkvist et al, 1993; Sikora et al, 2011). In V. 
cholerae, the T2S (eps) genes are encoded in a single operon which translates 
into 13 proteins that span the outer membrane, inner membrane, and the 
periplasm of Gram-negative bacteria (Korotkov et al, 2012). The T2S system can 
be broken down into four major components; the outer membrane porin (EpsD), 
the inner membrane platform (EpsC, EpsF, EpsL and EpsM), the ATPase 
(EpsE), and the pseudopilus (EpsG, EpsH, EpsI, EpsJ and EpsK) (Korotkov et al, 
2012) (Figure 1.2). The Eps proteins are well conserved among many other 
Gram-negative species, including nonpathogenic and pathogenic bacteria of 
humans, plants and aquatic organisms (Korotkov et al, 2012). 
All T2S substrates contain an N-terminal signal peptide that allows them to 
enter the Sec or Tat system. Cleavage of the signal peptide releases the proteins 
from the inner membrane to generate folded periplasmic intermediates. Each A 
and B subunit of CT is generated with its own N-terminal signal peptide. With the 
help of DsbA, a protein responsible for introducing disulfide bonds, the subunits 
assemble into the AB5 toxin to then engage the T2S system for outer membrane 
translocation (Figure 1.2) (Sandkvist, 2001).  
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Figure 1.2: Model for the T2S system and cholera toxin (CT) secretion.  
The A (red) and B subunits (purple) of CT are generated with a signal peptide 
that allows for inner membrane translocation via the Sec system. Once in the 
periplasm, the subunits fold into a multimer that can engage the secretion system 
to reach its final destination in the extracellular milieu. The T2S system is 
composed of a porin (EpsD), inner membrane platform (EpsC, F, L and M), the 
ATPase (EpsE), and the pseudopilus (EpsG, H, I, J and K).    
 
 
Although much research has been dedicated to understanding the role of 
each Eps protein and how they interact with each other, the process of substrate 
recognition and secretion still remains to be fully elucidated. It is believed that the 
folded T2S substrates gain entry to the apparatus via interaction with EpsD 
and/or EpsC (Bouley et al, 2001). Once the substrates enter the system and 
make contact with the pseudopilus, a signal is sent to EpsE, the ATPase, to 
generate energy from ATP hydrolysis (Camberg et al, 2007; Camberg & 
Sandkvist, 2005). The hydrolysis of ATP changes the conformation of EpsE (Lu 
et al, 2013; Patrick et al, 2011), which then may transduce energy to EpsL, the 
protein that couples EpsG (major component of the pseudopilus) and EpsE (Gray 
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et al, 2011). This results in extension of the pseudopilus, which may act as a 
piston to push the T2S substrates through the outer membrane porin to the 
extracellular milieu (Korotkov et al, 2012). 
While many T2S substrates diffuse away from the cell following outer 
membrane translocation, there are a few that are known to be surface-attached 
through various mechanisms. Several lipoproteins like pullulanase (PulA), SslE 
and OmcA from Klebsiella oxytoca, enteropathogenic Escherichia coli (EPEC) 
and Shewenella oneidensis, respectively, are found to be anchored to the cell 
surface (Rondelet & Condemine, 2013). Specifically, PulA was shown to be cell 
surface anchored through an N-terminal fatty acid moiety and is slowly released 
into the culture supernatant over time. In T2S mutants, PulA is found in the inner 
membrane due to the presence of aspartic acid at position 2, a residue 
responsible for keeping lipoproteins in the inner membrane (Pugsley et al, 1990). 
Mutants of PulA that localized to the periplasmic leaflet of the outer membrane 
prior to T2S are less efficiently localized to the cell surface than the wild type 
(WT) PulA, suggesting that the inner membrane intermediate of PulA is needed 
for efficient translocation to the cell surface by the T2S system (Pugsley & 
Kornacker, 1991). SslE and OmcA are believed to behave similarly to PulA 
because of their shared lipoprotein-specific signal peptide. Another mechanism 
of cell surface retention is seen with heat labile enterotoxin (LT) that engages the 
T2S system through a periplasmic intermediate similar to CT. Once translocated 
through the outer membrane it binds to lipopolysaccharides (LPS) on the cell 
surface (Horstman et al, 2004). Another example, PnlH, a cell-wall degrading 
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enzyme of Dickeya dadantii, is anchored to the cell surface through its 
noncleavable Tat signal peptide. In a T2S mutant, PnlH is found on the 
periplasmic side of the outer membrane (Ferrandez & Condemine, 2008). 
Whether T2S substrates are secreted away from the cell or remain on the 
surface, the recognition motifs of these substrates by the T2S system are 
unknown.    
T2S proteins may need to fold before engaging the secretion apparatus, 
suggesting that a structural motif is recognized (Hirst & Holmgren, 1987a). 
Moreover, the crystal structures of T2S substrates reveal that they are rich in β-
sheets, pointing to a possible recognition motif (Korotkov et al, 2012; Sandkvist, 
2001). In fact, studies on CT have shown that when each subunit is expressed 
and made separately, the β-rich B subunit of CT is secreted through the T2S 
system, whereas the A subunit remains in the periplasm. From this it was 
concluded that the B subunit contains the recognition motif for T2S and the A 
subunit comes along with the B subunit during secretion (Hirst et al, 1984). Other 
studies in various organisms have been done to identify a secretion motif by 
observing translocation of fusion proteins, where parts of a T2S substrate are 
fused to a reporter protein. Although some regions have been identified for 
secretion, they have been far too large to pinpoint specific domains or regions 
and no linear secretion signal has been identified. It is possible that the secretion 
signal may consist of different regions that come together in the folded protein 
(Korotkov et al, 2012).  
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Many T2S substrates including proteases, lipases, phosphatases and 
carbohydrate degrading enzymes, as well as toxins have been identified and as 
indicated above, play important roles in pathogenesis and/or environmental 
survival, highlighting the importance of the T2S system (Korotkov et al, 2012). In 
an effort to identify additional V. cholerae T2S substrates, our laboratory 
conducted proteomic analysis on supernatants of WT V. cholerae and a T2S 
mutant. Three related serine proteases were identified and named Vibrio 
extracellular serine protease A/B/C (VesA, VesB and VesC) (Sikora et al, 2011).  
 
Serine Proteases: 
There are over 80 families of serine proteases. The chymotrypsin family or 
S1, contains many serine proteases that function in digestion, blood clotting, 
fibrinolysis and complement activation (Rawlings & Barrett, 1994; Rawlings et al, 
2012). While serine proteases that function in digestion, like trypsin and 
chymotrypsin, contain a single domain, serine proteases like plasmin, 
complement component C1r and tissue plasminogen activator contain multiple 
domains that are N-terminal to the protease domain (Forneris et al, 2012; 
Hedstrom, 2002; Rawlings & Barrett, 1994; van Zonneveld et al, 1986). These 
additional domains regulate serine proteases by providing substrate specificity or 
membrane localization.  
Serine proteases are anchored to the membrane in various ways; either 
generated with an N- or C-terminal transmembrane extension or post-
translationally modified with a glycosylphosphatidylinositol (GPI) linkage (Antalis 
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et al, 2011). Prostasin, a GPI-linked serine protease, is cleaved at its C-terminal 
transmembrane domain and linked to GPI by GPI transamidase, which results in 
association with lipid rafts in the plasma membrane (Chen et al, 2001). Studies 
show that this protein can be released from the membrane via cleavage by GPI-
specific phospholipase D (Verghese et al, 2006). Membrane-anchored serine 
proteases still retain their protease activity without their GPI-anchor or 
transmembrane domains, suggesting that membrane-anchoring is important for 
properly localizing these proteins to a specific site but not for their activity (Antalis 
et al, 2011). 
Another mechanism of regulating serine proteases is the presence of 
additional domains that provide substrate specificity. Two subtilisin-like serine 
proteases, cucumisin from the plant Cucumis melo and Aeromonas sobris ASP, 
are known to contain an immunoglobulin-fold (Ig-fold) domain that interacts with 
the protease domain or is positioned close to the active site, suggesting a 
possible mechanism of controlling substrate specificity (Kobayashi et al, 2009; 
Murayama et al, 2012). Additionally, serine proteases of complement activation 
contain multiple domains that are involved with protein interactions and domain 
rearrangements, both of which lead to cleavage of specific substrates (Forneris 
et al, 2012).  
Another way by which serine proteases are regulated involves the binding 
of Na+ to augment protease activity. Studies have shown that residues 
surrounding and including tyrosine at position 225 in thrombin are important for 
Na+ ion binding and leads to enhanced activity; a regulation that is relevant to the 
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blood coagulation serine proteases (Dang & Di Cera, 1996; Di Cera et al, 1995). 
In contrast, the digestive enzyme trypsin contains a proline at the equivalent 
tyrosine 225 position of thrombin, which induces an orientation change of Lys224 
(thrombin numbering) and therefore the inability to coordinate Na+. (Guinto et al, 
1999). 
Regardless of the domain arrangement, subcellular location or manner of 
regulation, all serine proteases of the chymotrypsin family contain the catalytic 
triad residues serine, histidine and aspartic acid and are first made as a zymogen 
with an N-terminal propeptide. The propeptide is cleaved at the activation site, 
resulting in an active serine protease. Once activated, these proteins can 
degrade substrates or act in a cascade pathway where one activates another. 
Serine proteases of the chymotrypsin family are subdivided into three clans 
based on substrate specificity. A trypsin-like protease cleaves at an arginine or 
lysine residue. A chymotrypsin-like protease cleaves at a tryptophan, tyrosine or 
phenylalanine residue. An elastase-like protease cleaves after a small, 
uncharged residue (Hedstrom, 2002).  
The serine proteases of the chymotrypsin subfamily A or S1A are found 
mostly in eukaryotes and rarely in prokaryotes. Until recently, only serine 
proteases from the Gram-positive Streptomyces genus were present in this 
subfamily. The trypsin-like proteins SOT and SGT from S. omiyaenis and S. 
griseus, respectively, contain a signal peptide and are secreted into the culture 
supernatant (Uesugi et al, 2008). They preferentially cleave different types of 
collagen despite sharing 77% sequence identity and similar structures (Read & 
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James, 1988; Uesugi et al, 2008; Yamane et al, 1995). Studies indicated that two 
residues of SOT are important for substrate binding. When Tyr71 and Arg72 
were mutated, SOT lost the ability to hydrolyze collagen type I/IV. Furthermore, a 
variant of SGT that was genetically engineered to contain Tyr71 and Arg72 
gained the ability to cleave collagen type I/IV like SOT (Uesugi et al, 2011; 
Uesugi et al, 2009). The structure of SOT reveals that Tyr71 is close to Trp83, 
which is adjacent to the catalytic residue of the active site, Asp82, suggesting 
that once substrate binding occurs, a conformation change could result in 
activation of the enzyme and subsequent cleavage of substrates (Uesugi et al, 
2011). In addition to the serine proteases from the Streptomyces genus, the 
recently identified VesA, VesB and VesC from V. cholerae have been added to 
the S1A subfamily. My dissertation work focuses on VesB. 
 
Vibrio extracellular serine protease B: 
Vibrio extracellular serine protease B (VesB) contains an N-terminal signal 
peptide, a protease domain and a C-terminal domain with a GlyGly-CTERM 
extension (Figure 1.3). Sequence alignment of the protease domain of VesB and 
trypsinogen reveals 30% homology. The predicted catalytic triad, His-Asp-Ser, 
and the putative activation site of VesB are evident in these alignments. 
Additionally, VesB contains the equivalent tyrosine 225 of thrombin rather than 
proline of trypsin at this position, suggesting that Na+ ion binding may regulate 
activity. Preliminary analysis of culture supernatants revealed that VesB cleaves 
synthetic peptides at arginine, suggesting that VesB is a trypsin-like serine 
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protease (Sikora et al, 2011). At the very C-terminus, VesB contains a GlyGly-
CTERM domain, which includes Ser-Gly-Gly-Ser, followed by a stretch of 
hydrophobic residues and positively charged amino acids. This domain is 
predicted to be a transmembrane domain.  
Previous studies in our laboratory have shown that VesB is not required 
for infant mouse colonization, as a vesB mutant strain (ΔvesB) colonized similarly 
to the WT strain (Sikora et al, 2011). Contrary to our infant mouse data, 
additional large-scale analysis has implied a role of VesB in colonization or 
infection in both humans and infant rabbits. Proteomic analysis of bacteria 
isolated from stool samples of patients infected with V. cholerae identified VesB 
(LaRocque et al, 2008). Also, the expression of vesB was upregulated following 
cultivation of V. cholerae in the rabbit ileum loop model (Xu et al, 2003). 
Furthermore, using transposon insertion site sequencing, a vesB mutant was 
identified to have reduced colonization ability in infant rabbits following oral 
inoculation (Fu et al, 2013). In this same study, the T2S proteins and 
rhombosortase, a rhomboid like protease, were also found to be important for 
colonization (Fu et al, 2013).  
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Figure 1.3: Schematic diagram of VesB.  
A. VesB contains an N-terminal signal peptide in red, a protease domain in gray 
containing the activation site (green) and the residues of the catalytic triad 
(purple), and the C-terminal domain in light blue. At the very C-terminus, VesB 
contains the GlyGly-CTERM domain made up of two serine and glycines (red), 




Rhomboid proteases are one of the most highly conserved families of 
membrane proteases and found in all three domains of life (Brooks & Lemieux, 
2013). They function in many processes like mitochondrial remodeling and 
growth factor signaling, as well as host cell invasion by apicomplexan parasites 
(Freeman, 2008). In bacteria, it has been shown that rhomboid protease mutants 
of Bacillus subtilis are altered in cell division and glucose uptake and 
Mycobacterium smegmatis mutants display changes in biofilm formation, colony 
morphology and susceptibility to antibiotics (Rather, 2013). Even though these 
findings suggest a possible role for rhomboid proteases in these processes, their 
mechanisms and substrates are unknown. TatA, the channel-forming protein of 
the twin-arginine translocation (TAT) system is the only bacterial rhomboid 
protease substrate known. In Providencia stuartii, the rhomboid protease AarA 
cleaves TatA, which results in formation of the TAT system, a complex involved 
in the translocation of folded proteins across the inner membrane (Fritsch et al, 
2012; Stevenson et al, 2007).  
Rhomboid proteases contain six transmembrane domains that fold to form 
a Ser-His active site and some contain either an N- or C-terminal cytoplasmic 
domain (Figure 1.4). Although the cytoplasmic domain of the E. coli rhomboid 
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protease, GlpG, does not contribute to the stability or activity of the membrane 
domain, possible functions of the cytoplasmic domain includes providing 
substrate specificity, cellular compartmentalization or interacting with the 
membrane domains of rhomboid proteases (Lazareno-Saez et al, 2013). 
Crystallography studies on the E. coli and Haemophilus influenzae GlpG proteins 
show that the active site is 10 Å below the plane of the lipid bilayer, suggesting 
that proteolysis of substrates occurs within the membrane (Ben-Shem et al, 
2007; Lemieux et al, 2007; Wang et al, 2006; Wu et al, 2006) (Figure 1.4). In 
agreement with this, rhomboid proteases have been shown to cleave substrates 
at small residues within transmembrane domains that contain helix-destabilizing 
residues like prolines and glycines (Akiyama & Maegawa, 2007; Strisovsky et al, 
2009).  
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Figure 1.4: Crystal structure of GlpG from E. coli and the alignment of 
rhomboid protease (GlpG) and rhombosortase (RssP) from V. cholerae.   
A. The crystal structure of GlpG shows six transmembrane helices that form a 
water channel containing the two Ser-His active site residues. Figure prepared 
using Pymol, PDB: 2IRV (Ben-Shem et al, 2007).  
B. The sequence alignment of GlpG and RssP of V. cholerae. The catalytic dyad, 
Ser-His, is highlighted in red. The putative transmembrane domains are indicated 
as colored bars based on the transmembrane domains of E. coli GlpG.    
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In an effort to identify the important residues of the recognition motif, the 
transmembrane domains of native rhomboid protease substrates were fused to 
reporter proteins. In these studies, the helix-destabilizing residues were shown to 
be important for cleavage by rhomboid protease, as mutating those residues to 
more stabilizing residues did not result in cleavage. Conversely, when the 
transmembrane helix was mutated to contain more destabilizing residues, more 
substrate was cleaved by rhomboid protease (Akiyama & Maegawa, 2007; 
Strisovsky et al, 2009). Using the same fusion substrates with various point 
mutations, the specific residues cleaved by rhomboid protease were identified. 
The consensus was that rhomboid protease cleaves between amino acids with 
small side chains like alanines, serines and glycines (Akiyama & Maegawa, 
2007; Strisovsky et al, 2009). 
  
 
Rhombosortase and the GlyGly-CTERM domain: 
 
Recently, a bioinformatics study using partial phylogenetic profiling 
showed a possible link between a subfamily of rhomboid proteases, called 
rhombosortases, and proteins containing a GlyGly-CTERM domain. In genomes 
encoding only one GlyGly-CTERM domain protein, the gene was always found 
next to the rhombosortase gene; however, in genomes encoding many GlyGly-
CTERM domain proteins this arrangement was not maintained. The presence of 
the GlyGly-CTERM domain containing proteins and rhombosortase is exclusive 
to Gram-negative bacteria including Vibrio, Shewenella, Acinetobacter, Ralstonia 
and Aeromonas genera (Haft & Varghese, 2011). In V. cholerae, the genome 
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encodes both a rhomboid protease (GlpG) and rhombosortase protease (RssP). 
Protein sequence analysis reveals that rhombosortase contains the predicted 
catalytic dyad and the same topology as rhomboid protease; however, it is 
missing the N-terminal cytoplasmic domain (Figure 1.4) (Haft & Varghese, 2011). 
Because of the similarity to rhomboid protease, rhombosortase may also cleave 
substrates with a transmembrane domain. Due to their possible genomic 
connection and the tendency of GlyGly-CTERM domain containing proteins to 
have predicted transmembrane domains, proteins with the GlyGly-CTERM 
domain may be substrates for rhombosortase.  
In the aforementioned bioinformatics study, the transmembrane domains 
of 219 proteins containing the GlyGly-CTERM domain were analyzed for amino 
acid content and arrangement. The alignment of these proteins shows the typical 
length of the GlyGly-CTERM domain is 22 amino acids and consists of a tripartite 
motif. The arrangement of this domain includes an area rich in glycines and 
serines, followed by hydrophobic and positively charged residues. With the 
exception of the glycines and serines, the GlyGly-CTERM domain is similar to 
the LPXTG sorting motif, which is the target of sortase, a transpeptidase that 
anchors LPXTG-containing proteins to the surface of Gram-positive bacteria. The 
similarities between these motifs and the possibility that the rhombosortase may 
process the GlyGly-CTERM motif were the reasons for the name of this newly 
identified variant of rhomboid protease (Haft & Varghese, 2011).  Furthermore, 
the hydrophobic region of the GlyGly-CTERM domains deviate from typical 
transmembrane domains in that they contain more leucines than valines and 
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isoleucines, indicating that the transmembrane helix may be involved in specific 
protein-protein interactions with a membrane protein (Haft & Varghese, 2011).  
The role of the GlyGly-CTERM domain is not known. Interestingly, a few 
GlyGly-CTERM domain containing proteins were reported to have dual 
localization patterns. ExeM, an endonuclease from S. oneidensis was identified 
to be membrane associated using proteomics, but also had culture supernatant 
activity (Brown et al, 2010; Godeke et al, 2011; Tang et al, 2007). Additionally, 
the V. cholerae homolog of ExeM, Xds was shown to have activity in both the 
culture supernatant and cells (Newland et al, 1985; Seper et al, 2011). 
Furthermore, ExeM and Xds were shown to be important for biofilm formation 
and stability (Godeke et al, 2011; Seper et al, 2011). Collectively, these data 
suggest that the GlyGly-CTERM domain and rhombosortase may have a role in 
the dual localization of proteins, potentially highlighting a new protein sorting 
mechanism in Gram-negative bacteria.      
 
Protein Sorting Mechanisms: 
 A well-known protein sorting mechanism is the LPXTG/sortase system of 
Gram-positive bacteria. Sortase is a cysteine protease with a Cys-His active site. 
The sortase substrates contain an N-terminal signal peptide and a C-terminal 
sorting signal made up of 32 amino acids consisting of the LPXTG motif, followed 
by a hydrophobic domain and a positively charged tail (Figure 1.5-1). The peptide 
bond in between Thr and Gly in the LPXTG motif is cleaved by sortase (Figure 
1.5-4). This results in an acyl intermediate with sortase that is resolved by a 
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nucleophilic attack by the pentaglycines of the lipid II precursor of peptidoglycan 
(Figure 1.5-5). As peptidoglycan synthesis progresses, the LPXTG substrates 
are incorporated into the cell wall envelope to generate cell surface-anchored 
proteins in Gram-positive bacteria (Figure 1.5-6,7) (Marraffini et al, 2006).  
  
Figure 1.5: A schematic diagram of the LPXTG/sortase system.  
The LPXTG substrate (1) is composed of an N-terminal signal peptide (gray) and 
the C-terminal LPXTG motif. The transmembrane domain (red) and the positively 
charged residues (+) follow the LPXTG recognition sequence. The signal peptide 
is cleaved and the protein enters the membrane via the hydrophobic C-terminus 
(2-3). Sortase cleaves in between the Thr and Gly of the LPXTG motif (4), 
generating an acyl intermediate (5). The pentaglycines of lipid II acts as a 
nucleophile and links to Thr (5). This precursor is incorporated into 
peptidoglycan, resulting in a cell-wall anchored protein (6-7).  
  
 
Lesser-known protein sorting mechanisms are found in environmental 
bacteria and archaea and these are termed PGF-CTERM/archaeosortase and 
PEP-CTERM/exosortase, respectively (Haft et al, 2006; Haft et al, 2012). The 
PGF-CTERM/archaeosortase system is commonly found in archaea. Proteins 
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with PGF-CTERM domains have a recognition motif consisting of Pro-Gly-Phe 
(PGF) and a predicted hydrophobic domain followed by positively charged 
residues. Most substrates containing the PGF-CTERM domain are glycoproteins 
(Haft et al, 2012). For example, the S-layer glycoprotein from Haloferax volcanii 
was shown to retain its PGF-CTERM domain in the absence of archaeosortase, 
suggesting that archaeosortase cleaves the PGF-CTERM domain (Abdul Halim 
et al, 2013). Furthermore, S-layer glycoprotein was shown to undergo lipid 
modification once it transverses through the plasma membrane, however, the 
site of lipid modification is not known (Kandiba et al, 2013; Konrad & Eichler, 
2002).  
The PEP-CTERM domain is comprised of 24 amino acids and has a 
similar arrangement to the tripartite motif of the LPXTG, PGF-CTERM and 
GlyGly-CTERM domains. A bioinformatics study using partial phylogenetic 
profiling identified EpsH, a protein involved in extracellular polysaccharide 
biosynthesis, as the potential exosortase enzyme that could cleave the PEP-
CTERM domain and assist in sorting. Although the sequence identity of EpsH 
and sortase are low, they contain the same conserved Cys-His active site 
residues, suggesting that these enzymes may act in a similar fashion (Haft et al, 
2006). Very little is known about where the modifying enzymes cleave and the 
exact mechanism of cell surface anchoring of their substrates.  
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Significance and Scope of this Study:    
Although the exact role of VesB in V. cholerae pathogenesis and 
environmental survival is unknown, it has been identified in various large-scale 
analyses to have possible roles in colonization and disease progression (Fu et al, 
2013; LaRocque et al, 2008; Xu et al, 2003). Apart from this, the unique domain 
arrangement consisting of a trypsin-like protease domain and a C-terminal 
domain containing the GlyGly-CTERM extension has led me to study VesB in 
detail. The overall goal of my dissertation project is to dissect the protease 
domain and understand the role of the GlyGly-CTERM domain and its 
relationship to rhombosortase and T2S. 
Until VesB was discovered, the only other bacterial trypsin-like serine 
proteases from the chymotrypsin subfamily (S1A) under investigation were SGT 
and SOT. They were shown to cleave different forms of collagen based on their 
residue content at particular positions and studies focused on their structure 
revealed a resemblance to trypsin (Read & James, 1988; Uesugi et al, 2008; 
Uesugi et al, 2011; Uesugi et al, 2009; Yamane et al, 1995). Even though the 
protease domain of VesB is predicted to have a trypsin-like fold, VesB sets itself 
apart from SGT and SOT in that it contains the equivalent Tyr250 motif of 
thrombin, indicating a possible role of Na+ regulation. Additionally, VesB has a C-
terminal domain that SGT and SOT lack.  
In the second chapter, I sought to understand the catalytic triad and 
activation site of the protease domain, as well as determine substrate specificity 
and the effects of Na+ on the activity of VesB. Furthermore, my colleague 
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Konstantin Korotkov, solved the structure of the two-domain VesB protein. Taken 
together, our combined work revealed that VesB is a trypsin-like protease with a 
typical trypsin-like fold and a C-terminal Ig-fold. It also demonstrated that the 
presence of Na+ does not enhance VesB activity.   
I next wanted to study the role of the GlyGly-CTERM domain of VesB. 
VesB was believed to be fully secreted away from cells, as it was identified in V. 
cholerae culture supernatants. Therefore, the presence of an unusual putative 
transmembrane motif, the GlyGly-CTERM, motivated us to study this domain in 
detail along with its connection to the T2S system. My main question dealt with 
the presence of the putative transmembrane domain and its possible removal for 
extracellular release. Shortly thereafter, Haft et. al. published a paper showing 
the genetic co-existence of proteins with the GlyGly-CTERM domain and 
rhombosortase, a subfamily of rhomboid proteases (Haft & Varghese, 2011). 
Rhomboid proteases are known to cleave substrates with a single 
transmembrane domain (Akiyama & Maegawa, 2007; Strisovsky et al, 2009). 
This led to my hypothesis that rhombosortase may cleave the GlyGly-CTERM 
domain of VesB, resulting in extracellular release. However, after generating 
antibodies against VesB, I found that most of VesB is cell-associated, the 
secreted VesB is the same size as the cell-associated form and both forms are 
active. This led me to therefore predict that rhombosortase cleaves and perhaps 
modifies the GlyGly-CTERM domain of VesB to keep it on the cell surface, 
analogous to the sortase/LPXTG system.  
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The third chapter details my work on the biogenesis of VesB, specifically 
the relationship between the GlyGly-CTERM domain, rhombosortase, and the 
T2S system. Using western blot analysis, activity assays and cell-staining with 
microscopy, I show that VesB is a T2S-dependent cell surface localized protein. 
Furthermore, I demonstrate that rhombosortase cleaves and possibly modifies 
the GlyGly-CTERM domain to retain VesB on the cell surface. Also, I show that 
in the absence of rhombosortase, V. cholerae’s rhomboid protease, GlpG, can 
cleave the GlyGly-CTERM domain of VesB and this cleavage leads to an 
alternative phenotype where VesB is secreted completely from the cell, however, 
this form of VesB is inactive.  
 Together, my dissertation work contributes to a better understanding of a 
multi-modular bacterial serine protease and introduces a novel protein sorting 
mechanism in Gram-negative bacteria. This project opens an exciting avenue of 
research for the GlyGly-CTERM/rhombosortase system, which will be discussed 
in chapter 4. The information learned from these studies can be extrapolated to 
other GlyGly-CTERM domain containing proteins that may function in 
pathogenesis or survival of bacteria, and may identify ways to target the GlyGly-
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CHAPTER 2: 
Functional and Structural Characterization of 






A modified version of this chapter was previously published in the Journal 
of Biological Chemistry (Gadwal et al, 2014). 
 






The chymotrypsin subfamily A of serine proteases consists primarily of 
eukaryotic proteases, including only a few proteases of bacterial origin. VesB, a 
newly identified serine protease that is secreted by the type II secretion system in 
Vibrio cholerae, belongs to this subfamily. VesB is likely produced as a zymogen 
since sequence alignment with trypsinogen identified a putative cleavage site for 
activation and a catalytic triad, His-Asp-Ser. Using synthetic peptides, VesB 
efficiently cleaved a trypsin substrate, but not chymotrypsin and elastase 
substrates. VesB was also capable of cleaving intact proteins such as BSA, 
casein, IgA and lactoferrin, suggesting that it may be a promiscuous protease 
with broad specificity. The reversible serine protease inhibitor, benzamidine,
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inhibited VesB and served as an immobilized ligand for VesB affinity purification, 
further indicating its relationship with trypsin-like enzymes. Consistent with this 
family of serine proteases, N-terminal sequencing implied that the propeptide is 
removed in the secreted form of VesB. Separate mutagenesis of the activation 
site and catalytic serine rendered VesB inactive, confirming the importance of 
these features for activity, but not for secretion. Similar to trypsin but, in contrast 
to thrombin and other coagulation factors, Na+ did not stimulate the activity of 
VesB, despite containing the Tyr250 signature. The crystal structure of 
catalytically inactive pro-VesB revealed that the protease domain is structurally 
similar to trypsinogen. The C-terminal domain of VesB was found to adopt an 
immunoglobulin (Ig) fold that is structurally homologous to Ig folds of other 
extracellular Vibrio proteins. Possible roles of the Ig fold domain in stability, 
substrate specificity, cell surface association and type II secretion of VesB, the 




Many bacteria require secretion of a variety of proteins for optimal 
adaptation to the diverse environments they encounter. One of the several 
bacterial protein secretion machineries is the type II secretion (T2S) system. This 
large two-membrane spanning assembly is remarkable in that it translocates 
multidomain and sometimes multimeric proteins in folded form across the outer 
membrane of Gram-negative bacteria (Douzi et al, 2012; Korotkov et al, 2012; 
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McLaughlin et al, 2012). In Vibrio cholerae, the T2S system is responsible for the 
secretion of cholera toxin (CT), the major virulence factor, and a large number of 
enzymes, including proteases into the extracellular milieu (Sandkvist et al, 1993; 
Sikora et al, 2011) 
Proteases are naturally occurring enzymes that are found in all domains of 
life. One of the largest classes of proteases, serine proteases, contains over 
eighty families. The S1, or chymotrypsin family consists of structurally 
homologous endoproteases with conserved His, Asp, and Ser residues that form 
the catalytic triad of the active site. Most members of this family are secreted as 
inactive precursors, or zymogens, with an N-terminal propeptide. The propeptide 
is proteolytically cleaved at a conserved activation site, which induces a 
conformational change that results in an active enzyme (Hedstrom, 2002; 
Rawlings & Barrett, 1994).  
Although structurally very similar, members of the chymotrypsin family are 
further subdivided into three groups based on substrate specificity. Trypsin-like 
proteases cleave at an arginine or lysine residue, chymotrypsin-like proteases 
act on tryptophan, tyrosine, or phenylalanine, and elastase-like proteases target 
small, uncharged residues (Hedstrom, 2002). Eukaryotic proteases of the 
chymotrypsin family are important for many cellular processes. Functionally, they 
aid in digestion, blood coagulation, complement activation, inflammation and 
development (Hedstrom, 2002). While the digestive enzymes, trypsin and 
chymotrypsin, are single domain proteases, proteins like tissue plasminogen 
activator, plasmin, and the complement component C1r contain multiple 
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regulatory domains that are N-terminal to the protease domain (Forneris et al, 
2012; Rawlings & Barrett, 1994; van Zonneveld et al, 1986). Furthermore, some 
chymotrypsin family proteases are anchored to membranes by either 
glycosylphosphatidylinositol (GPI), a single-pass transmembrane domain at the 
C-terminus, or a signal anchor at the N-terminus (Szabo & Bugge, 2011).  
  The S1A, or chymotrypsin A subfamily, consists primarily of eukaryotic 
proteases, however, a few bacterial serine proteases belong to this subfamily 
according to the peptidase database MEROPS (Rawlings et al, 2013). To date, 
proteases that are structurally related to trypsin have been identified in 
Streptomyces species (Read & James, 1988; Yamane et al, 1995). These were 
shown to contain a single protease domain that has collagenolytic activity (Read 
& James, 1988; Uesugi et al, 2008; Yamane et al, 1995). In addition, we recently 
identified three related Vibrio cholerae extracellular serine proteases, VesA, 
VesB, and VesC, in a proteomic screen designed to detect proteins secreted via 
the T2S system (Sikora et al, 2011). Consistent with their reliance on the T2S 
system for extracellular secretion, when overexpressed, measurable activity of all 
three proteases has been detected in culture supernatants of V. cholerae (Sikora 
et al, 2011; Syngkon et al, 2010). Furthermore, these proteases have a predicted 
N-terminal signal peptide that allows them to enter the periplasm via the Sec 
pathway prior to engaging with the T2S system (Filloux, 2004). In addition, they 
all consist of an N-terminal protease domain containing a putative activation site, 
residues that comprise the catalytic triad, and a C-terminal domain that varies in 
length and includes a GlyGly-CTERM extension of unknown function (Figure 2.1) 
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(Haft & Varghese, 2011). The domain organization of VesA, VesB and VesC 
differs from that of most bacterial and eukaryotic trypsin-like proteases in that the 
additional non-protease domain is positioned at the C-terminus.  
 
 
Figure 2.1: Schematic diagrams of VesA, VesB, and VesC.  
All three contain an N-terminal signal peptide in light blue, an N-terminal protease 
domain in purple, a C-terminal domain in dark blue with the highlighted Ig-fold 
domain in light blue, and the GlyGly-CTERM extension in yellow. The N-terminal 
protease domain contains the predicted activation site indicated by the arrow and 
the catalytic triad comprised of His, Asp, and Ser.  
 
VesB, the focus of this study, shares approximately 30% sequence 
identity with trypsin and other members of the S1A family of serine proteases and 
displays a similar positioning of its catalytic residues. While the biological role of 
VesB has yet to be determined, VesB is produced both in vitro and in vivo. 
Besides its detection in laboratory-grown cultures, VesB has also been detected 
in V. cholerae that was isolated from stools of patients with clinical cholera, 
inferring that VesB may contribute to intestinal growth or pathogenesis 
(LaRocque et al, 2008; Sikora, 2013; Sikora et al, 2011). Also, intestinal vesB 
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gene expression was detected in V. cholerae cultivated in a rabbit ileum loop, an 
experimental model for cholera, further suggesting a possible role in survival or 
disease (Xu et al, 2003). While VesB may contribute to intestinal growth of V. 
cholerae, it is not the only factor required for intestinal survival as vesB 
inactivation had no negative effect on infant mice colonization (Sikora et al, 
2011). Finally, VesB is capable of cleaving the A subunit of CT, a process 
important for CT activation (Gordon & Leppla, 1994; Sikora et al, 2011).   
The rarity of characterized bacterial serine proteases in the chymotrypsin 
A subfamily, the unique domain arrangement, and the possible role of VesB in 
intestinal growth or pathogenesis led us to study VesB in detail. Here, we focus 
on the activity and structure of VesB. We show that the protease domain of pro-
VesB contains a trypsin-like fold with an incomplete oxyanion hole, and an 
additional C-terminal domain with an Ig fold containing seven β-strands and two 
short α-helices. Furthermore, we show that purified VesB has activity against 
synthetic peptides, cleaves after Arg independently of Na+ ions, can be inhibited 
by serine protease inhibitors, and is produced with a propeptide that is critical for 
activity but not for extracellular secretion by V. cholerae.  
 
Results: 
Purification of secreted VesB: 
To determine whether benzamidine sepharose could be utilized for affinity 
purification of native VesB, the reversible serine protease inhibitor benzamidine 
was analyzed for its ability to inhibit VesB activity. Specifically, VesB was 
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overexpressed from pMMB67EH-vesB in ΔvesABC, a V. cholerae strain lacking 
all three serine protease genes vesA, vesB and vesC (Sikora et al, 2011). 
Culture supernatant was isolated and incubated with increasing amounts of 
benzamidine, and then subjected to a kinetic protease activity assay using the 
synthetic peptide Boc-Gln-Ala-Arg-7-amido-4-methylcoumarin as a substrate. 
The results showed that as the concentration of benzamidine increased the 
activity of VesB decreased, suggesting that benzamidine is binding to VesB and 
that benzamidine-sepharose can be used for the purification of VesB (Figure 
2.2A). To purify VesB, culture supernatant was isolated, concentrated and 
applied to benzamidine-sepharose chromatography. VesB was eluted with 
benzamidine and all of the fractions were analyzed by SDS-PAGE followed by 
GelCode blue and silver staining (Figure 2.2B-C). The GelCode blue and silver 
stained gels showed that some VesB was found in the flow-through fraction (lane 
4), while there was no additional loss of VesB during washing (lanes 5-10). 
Bound VesB eluted efficiently with 100 mM benzamidine (lanes 11-14) and once 
benzamidine was removed the activity of VesB could be measured (Figure 2.3). 
Antibodies were then raised against the purified material and the saved fractions 
were analyzed by SDS-PAGE and immunoblotting with anti-VesB antiserum 
(Figure 2.2D). 
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Figure 2.2: VesB purification by benzamidine-sepharose affinity 
chromatography.  
A. The supernatants of ∆vesABC strains with pMMB67EH (p) or pVesB were 
incubated for 10 minutes at 37°C with different concentrations of the serine 
protease inhibitor, benzamidine, and the protease activity was measured 
(experiments were done in triplicates and S.E. bars are shown).  
B-D. The supernatant from ∆vesABC overexpressing VesB (lane 1) was added to 
60% saturation of ammonium sulfate and the precipitated material (Lane 2) and 
supernatant (Lane 3), were separated by centrifugation. The pellet was 
resuspended and dialyzed in 50 mM Tris-HCl, pH 8.0, 450 mM NaCl. The sample 
was used for affinity chromatography using a benzamidine-sepharose column. 
Flow-through fraction was discarded (Lane 4) and the column was washed with 
50 mM Tris-HCl, pH 8.0, 450 mM NaCl (Lanes 5-10). VesB was eluted using 100 
mM benzamidine (Lanes 11-14). The samples were analyzed by SDS-PAGE and 
GelCode blue staining (B), silver staining (C) or Western blotting with anti-VesB 
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Characterization of purified secreted VesB:   
Previously, we have shown that Boc-Gln-Ala-Arg-7-amido-4-
methylcoumarin is cleaved when incubated with supernatant from V. cholerae 
overexpressing VesB and that this activity is inhibited by common serine 
protease inhibitors ((Sikora et al, 2011) and Figure 2.2A). To further determine 
the substrate specificity and verify that purified VesB is inhibited by serine 
protease inhibitors, we added purified VesB to different commercially available 
synthetic peptides that are conjugated to 7-amido-4-methylcoumarin (AMC) 
(Table 2.1 and Figure 2.3A) and preincubated VesB with different inhibitors 
(Figure 2.3B). VesB efficiently cleaved the trypsin substrate Boc-Gln-Ala-Arg-
AMC, while the plasmin and aminopeptidase substrates, Boc-Glu-Lys-Lys-AMC 
and Leu-AMC, respectively, were cleaved with greatly reduced efficiency, and no 
cleavage was observed for the chymotrypsin or elastase substrates (Table 2.1). 
Measurement of kinetic parameters yielded Vmax and KM values of 0.137 ± 
0.0030 nmol/min and 0.0327 ± 0.0025 mM, respectively, for Boc-Gln-Ala-Arg-
AMC (Figure 2.3A).  We were unable to determine Vmax and KM for Boc-Glu-
Lys-Lys-AMC and Boc-Leu-AMC as the reactions never approached maximum 
rates due to the lack of solubility of the substrates at higher concentrations. In 
addition, we observed inhibition of purified VesB activity by the serine protease 
inhibitors benzamidine and leupeptin, while VesB was not affected by the 
presence of the metal chelator, EDTA (Figure 2.3B). We also determined if VesB 
could degrade intact proteins by incubating various concentrations of VesB with 
readily available proteins, including BSA, casein, lactoferrin, and IgA. The 
	   34	  
samples were analyzed by SDS-PAGE and GelCode blue staining (Figure 2.4). 
The results suggest that VesB is capable of cleaving several intact protein 
substrates (Figure 2.4). Taken together, our results suggest that VesB is an 
extracellular trypsin-like protease that may have a preference for arginine at the 
P1 position of substrate(s) (using the commonly accepted nomenclature 
(Schechter & Berger, 1967)) and does not require divalent metal ions for activity. 
While the natural targets of VesB are unknown, VesB may be a promiscusous 
protease with broad specificity and multiple targets.  
Table 2.1. Proteolytic activity of VesB   
Peptide Sequencea VesB Activity (nmol 
AMC/min/nmol VesB)b 
Suc-Ala-Ala-Ala-AMC 0  
Suc (OMe)-Ala-Ala-Pro-Val-AMC 0 
Z-Leu-Arg-Gly-Gly-AMC 0 
Leu-AMC 0.518 ± 0.124 
Suc-Ala-Ala-Pro-Phe-AMC 0 
Boc-Glu-Lys-Lys-AMC 0.449 ± 0.060 
Boc-Gln-Ala-Arg-AMC 286 ± 34.0 
Boc-Gln-Ala-Arg-AMC + 200 mM NaCl 122 ± 21.9 ** 
Boc-Gln-Ala-Arg-AMC + 400 mM NaCl 137 ± 31.3 ** 
Boc-Gln-Ala-Arg-AMC + 600 mM NaCl 110 ± 18.9 ** 
Boc-Gln-Ala-Arg-AMC + 800 mM NaCl 97.2 ± 21.6 ** 
 
a Peptide sequence of the substrates all conjugated to 7-Amino-4-
methylcoumarin (AMC).  
b Substrate concentration was 0.05 mM. VesB concentration was 0.079 µg/mL 
when Boc-Gln-Ala-Arg-AMC was analyzed and 7.9 µg/mL for all other substrates. 
Experiments were done in triplicates and the mean and standard error are 
shown.  
** p values < 0.01: all compared to the sample with no NaCl 
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Figure 2.3: Protease activity of purified VesB.  
A. VesB activity was measured with different concentrations of Boc-Gln-Ala-Arg-
7-amido-4-AMC in 5 mM HEPES (pH 7.5) at 37◦C.  
B. Purified VesB (0.08 µg/mL) was incubated with 50 µM leupeptin, 1 mM 
benzamidine, or 10 mM EDTA for 10 minutes at 37°C. The Boc-Gln-Ala-Arg-7-
amido-4-AMC (0.05 mM final concentration) was added and VesB activity was 
measured. All experiments were done in triplicates and S.E. bars are shown.  
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Figure 2.4: VesB degrades intact proteins.  
Various concentrations of purified VesB (0-40 µg/mL) were incubating with 
different substrates (in red) for 1 hour at 37◦C. Samples were analyzed by SDS-




VesB is produced as a zymogen:   
The alignment of trypsin, thrombin and the protease domain of VesB 
revealed two important features of the chymotrypsin family of serine proteases: 
the catalytic triad and an activation site, with the latter corresponding to residues 
Arg32-Ile33 in pro-VesB (Figure 2.1). To verify cleavage at the predicted 
activation site, purified VesB was subjected to N-terminal sequencing by Edman 
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degradation. The sequence of the first five residues, IINGS, indicated that the 
propeptide had been removed from VesB and that VesB is cleaved at Arg32Ile33 
similar to other trypsin-like proteases. To determine if cleavage of the propeptide 
is necessary for VesB activity, we mutated the vesB gene to replace the 
activation site residue Arg 32 with Glu. In another variant, the putative catalytic 
residue Ser 221 was replaced with Ala. The mutant proteins were expressed in 
the V. cholerae strain ΔvesABC and supernatants and cells were isolated and 
subjected to analysis of protease activity (Figure 2.5A) and immunoblotting with 
VesB antiserum (Figure 2.5B). Both VesB-S221A and VesB-R32E were 
expressed and secreted in amounts similar to WT VesB (Figure 2.5B). However, 
VesB-S221A and VesB-R32E were deficient in cleaving the synthetic peptide 
Boc-Gln-Ala-Arg-AMC (Figure 2.5A). Although the immunoblot suggested that a 
fraction of VesB-R32E is cleaved, the site of cleavage is unknown and does not 
result in an active protease. Taken together, the activation site and catalytic triad 
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Figure 2.5: Protease activity and secretion of VesB-S221A and VesB-R32E. 
The vesB gene was subjected to site-directed mutagenesis and the obtained 
vesB-S221A and vesB-R32E constructs were cloned into pMMB67EH and 
expression was induced with 1 µM IPTG in the ∆vesABC strain.  
A. The culture supernatants of ∆vesABC strains with pMMB67EH (p), pVesB, 
pVesB-S221A, and pVesB-R32E were analyzed for protease activity. The data of 
VesB was compared to the data of the three strains to generate p values.  
B. The supernatants (S) and cell extracts (C) were isolated from the bacterial 
cultures of ∆vesABC strains with pMMB67EH, VesB, VesB-S221A, and VesB-




Structure of pro-VesB:  
As the yield of VesB purified from V. cholerae culture supernatant was not 
sufficiently high for crystallization, a soluble variant of VesB comprising residues 
24-373, but lacking the C-terminal residues 374-403, that contain the C-terminal 
GlyGly-CTERM extension, was expressed in E. coli and purified for crystallization 
and structure determination. To overcome a putative overexpression toxicity, the 
catalytic Ser221 of VesB was replaced with Ala. Crystallization trials produced 
crystals that yielded X-ray diffraction data to 2.4 Å (Table 2.2). The structure was 
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solved by a combination of molecular replacement and single wavelength 
diffraction methods using a sodium iodide derivative crystal. The structure was 
refined to Rwork/Rfree of 0.187/0.236 with good geometry (Table 2.2).  
Table 2.2. Data collection and refinement statistics  
 Native (PDB 4LK4) NaI derivativea 
Data collection   
Wavelength (Å) 0.9999 1.5418 
Space group P42212 P42212 
Cell dimensions     
    a, b, c (Å) 121.57, 121.57, 
71.31 
121.44, 121.44, 71.86 
    α, β, γ  (°)  90, 90, 90 90, 90, 90 
Resolution (Å) 46.3–2.40 (2.53–
2.40)b 
33.9–3.20 (3.37–3.20) 
Rsym 0.065 (0.985) 0.154 (0.683) 
I / σI 20.4 (2.5) 14.9 (3.6) 
Completeness (%) 99.5 (99.9) 99.9 (100) 
Multiplicity 6.3 (6.5) 7.7 (7.6) 
   
Refinement   
Resolution (Å) 46.3–2.40  
No. reflections (total / free) 21376 / 1070  
Rwork / Rfree 0.187 / 0.236  
No. atoms   
    Protein 2465  
    Ligand/ion 0  
    Water 93  
B-factors   
    Protein 60.2  
    Water 48.0  
    Wilson B 59.0  
R.m.s. deviations   
    Bond lengths (Å) 0.012  




    Favored 97.5  
    Outliers 0.0  
a Friedel pairs are treated as different reflections.  
b Values in parentheses are for the highest-resolution shell.  
c Calculated using the MolProbity server (http://molprobity.biochem.duke.edu) 
(Chen et al, 2010).  
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Figure 2.6: Crystal structure of pro-VesB.  
A. The crystal structure is shown in ribbon representation with α-helices in purple 
and β-strands in green. The insert on the right shows the catalytic triad residues 
Asp125, His78 and Ser221. Note that Ser221 was substituted to Ala to alleviate 
possible toxicity during protein expression. The disordered loops are indicated by 
dotted lines.  
B. The structure of VesB in surface representation. The protease domain of VesB 
is shown in light green and the Ig domain in dark green. The catalytic triad 
residues are colored in orange. Note that the catalytic site is not blocked by the 
Ig fold domain. 
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The crystal structure revealed that pro-VesB consists of two domains: an 
N-terminal protease domain with a typical trypsin/chymotrypsin fold and a C-
terminal domain with an Ig fold (Figure 2.6). The structure of the protease domain 
of pro-VesB can be superimposed onto the bovine trypsinogen structure (PDB 
1TGB, (Fehlhammer et al, 1977)) with an r.m.s.d. of 1.7 Å with 34% sequence 
identity for 198 residues (Figure 2.7). While there are two conserved disulfide 
bonds, Cys63-Cys79 and Cys190-Cys208, that are clearly present in the crystal 
structure, a putative Cys217-Cys244 disulfide is not visible as both Cys residues 
are part of disordered regions in pro-VesB. The protease domain of pro-VesB 
was captured in an inactive conformation in our structure either because E. coli 
does not express a protease that is capable of cleaving VesB and/or VesB is 
unable to undergo autocatalysis due to the Ser221Ala substitution. Residues 24-
32, corresponding to the N-terminal propeptide sequence, were present in the 
crystallized protein, although most of the propeptide is disordered in the crystal. 
Due to the presence of the intact propeptide, the side chain of residue Ile33, 
which would be the N-terminal residue in the active form of VesB, cannot occupy 
the hydrophobic pocket lined by residues Val159 and Val180. Instead, this 
hydrophobic pocket in the current structure is occupied by Ile164, which prevents 
the correct orientation of Asp220 that, based on homology with trypsin and 
trypsinogen ((Fehlhammer et al, 1977; Marquart, 1983); PDB 2PTC and 1TGB), 
should coordinate the N-terminal amino group of Ile33 in active VesB (compare 
Figure 2.8A and B). These structural features probably contribute to the disorder 
of three loops in the vicinity of the active site, which include residues 166-172, 
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214-217 and 244-247 (Figure 2.6A). Consistent with VesB being a trypsin-like 
protease, the disordered loops in pro-VesB are reminiscent of the disordered 
loops in the crystal structure of bovine trypsinogen (Fehlhammer et al, 1977).   
 
Figure 2.7: Similarities between pro-VesB, trypsinogen, thrombin and 
Streptomyces griseus trypsin.  
A. Stereo view of superposition of the protease domain of pro-VesB and 
trypsinogen (PDB 2PTC, (Marquart, 1983)). VesB is shown in the same colors as 
in Figure 5A, i.e. with α-helices in purple and β-strands in green; trypsinogen is 
shown in cyan. The catalytic triad residues of both proteases are shown as 
sticks.  
B. Structure-based sequence alignment of VesB, S. griseus trypsin (SGT), 
bovine trypsinogen and human thrombin (trypsin template numbering for 
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trypsinogen and thrombin (Fehlhammer et al, 1977)). Catalytic triad residues are 
highlighted in blue. Tyr250 of VesB, at a position equivalent to that of Tyr225 in 
thrombin is highlighted in cyan. In thrombin, this residue is involved in Na+ 
binding (but neither in SGT, trypsinogen or VesB, see text), Conserved Cys 
residues that form disulfide bonds are highlighted in yellow, note that the disulfide 
C217-C244 was invisible in the pro-VesB structure due to flexibility. The three 
disordered loops in the pro-VesB crystal structure are indicated with dotted lines 
above the top sequence. The sequence numbers on top are those of VesB, at 
the bottom those of thrombin. The alignment was rendered using the ESPript 
server (Gouet et al, 2003).   
 
In thrombin, residues Tyr184, Arg221, and Lys224 were shown to 
coordinate a Na+ ion that binds to and allosterically enhances thrombin activity 
(Dang & Di Cera, 1996; Di Cera et al, 1995). While the catalytic activity of several 
other coagulation and complement factors is also enhanced by sodium, trypsin is 
not. In the Na+-activated members of the trypsin-like family, Tyr 225 (thrombin 
numbering) plays a critical role. A proline residue at this position changes the 
orientation of the nearby Lys224 such that its carbonyl O atom can no longer 
coordinate Na+ (Dang & Di Cera, 1996). When thrombin residue Tyr225 was 
replaced with a Pro, as occurs in several trypsin-like proteases which are not 
Na+-sensitive, there was a loss in Na+ activation (Dang & Di Cera, 1996). The 
sequence alignment of VesB with thrombin shows that the residue corresponding 
to thrombin’s Tyr225 is Tyr250 in VesB (Figure 2.7B) i.e. a residue that is 
compatible with Na+ activation. The structural superposition of pro-VesB and 
thrombin is shown in Figure 7C, specifically highlighting the position of Tyr225 
and surrounding residues in thrombin and the corresponding residues in pro-
VesB. However, no sodium or other ions are apparent in the pro-VesB electron 
density (Figure 2.8D). The absence of sodium may be due to the inability of pro-
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VesB to coordinate sodium. Similarly, sodium is not present in the zymogen 
forms of thrombin (Pozzi et al, 2013). Thus, the structure of pro-VesB does not 
provide insight into the presence of a putative Na+ binding site in active VesB. To 
establish whether active VesB can be stimulated by Na+, we determined the 
activity of purified VesB in the absence and presence of increasing 
concentrations of NaCl using Boc-Gln-Ala-Arg-AMC (Table 2.1). The presence of 
Na+ did not stimulate VesB, instead we observed a decrease in activity (Table 
2.1). When a different substrate with Arg at the P1 position (Z-Gly-Gly-Arg-AMC) 
was tested, a similar negative effect on the VesB activity was observed (not 
shown). In addition, we isolated culture supernatant from a V. cholerae culture 
grown in a medium without NaCl and determined the activity of VesB in the 
absence or presence of 200 mM NaCl. There was no change in VesB activity 
when 200 mM NaCl was included (data not shown). Taken together, VesB does 
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FIGURE 2.8: Close-up 
views of the activation 
site and the Tyr250 
region of pro-VesB.  
A. Stereo view of the 
activation site of VesB. 
Selected residues 
including Ile33 are 
shown in stick 
representation and 
labeled. σA-weighted 
2FO-FC map is shown as 
grey mesh (contoured at 
1σ).  
B. Stereo view of 
equivalent region in 
trypsin is shown (PDB ID 
2PTC). Note that the N-
terminal Ile16 residue 
occupies the 
hydrophobic pocket 
formed by Ile138 and 
Ile158, and coordinates 
Asp194.  
C. Stereo view of 
superposition of Na+ 
binding loop of thrombin 
(magenta) and the 
equivalent loop of pro-
VesB (green). Na+ ion is 
shown as a purple 
sphere.  
D. The same view as in 
(C) showing σA-weighted 
2FO-FC map as grey 
mesh (contoured at 1σ) 
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 The crystal structure of the C-terminal non-protease domain of VesB 
revealed a domain rich in β-strands that adopts an Ig fold (Figure 2.6). A 
structural similarity search with the Dali server identified a number of distant 
homologs with Ig folds (Table 2.3). While the best hit was a domain from a 
Porphyromonas gingivalis protein of unknown function (Z factor = 9.3 and 12 % 
amino acid sequence identity), homologs of possibly greater interest are domains 
from bacterial PapD-like chaperones such as SfaE (Z factor = 8.2) and subtilisin-
like proteases like cucumisin (Z factor = 7.7). Superpositions of the C-terminal 
domain of VesB with SfaE and cucumisin domains are shown in Figure 2.9. 
Interestingly, VesB contains two additional short α-helices compared to the other 
proteins, and two extra β-strands compared to SfaE. We also observed a degree 
of structural homology, albeit less closely than with the previous three homologs, 
between the Ig domain of VesB and domains from several extracellular Vibrio 
proteins, including chitin-binding protein (GbpA), chitinase (ChiA), rugose and 
biofilm structure modifier (RbmA), and another protease of V. cholerae (PrtV) 
(Table 2.3). The Ig domain of GbpA has been reported to support its V. cholerae 
surface association (Wong et al, 2012), while the Ig domain of ChiA is a 
carbohydrate binding module (Songsiriritthigul et al, 2008). While we were unable 
to detect binding of purified VesB to chitin-Sepharose, suggesting that VesB is 
not a chitin-binding protein (data not shown), we have observed that a large 
fraction of extracellular VesB is surface associated (Gadwal et al., manuscript in 
preparation). We have not yet confirmed a role for the Ig domain in this 
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interaction as the removal of the Ig domain of VesB results in an unstable protein 
that cannot be detected when expressed in V. cholerae (data not shown).  
Table 2.3. Structural homologs of the C-terminal domain of VesB  
 





PDB ID Reference 
Unknown 
function 
9.3  2.5  94  12  2QSV N/A 
SfaE 8.2  2.7  92 5 1L4I 65 
Cucumisin 7.7 2.7 91 11 3VTA 57 
RbmA 7.0 2.6 88 10 4KKQ 61 
GbpA 5.8 3.4 84 11 2XWX 44 
ChiA 4.5 3.7 73 11 3B8S 45 
PrtV 3.7 2.8 63 17 4L9D 60 
KP-43 2.3 2.9 60 7 1WMD 59 
ASP 2.0 2.9 59 10 3HJR 58 
 
1 Z-score from the Dali server 
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Figure 2.9: Structural homologs of the C-terminal domain of VesB.  
A. Stereo view of superposition of the C-terminal domain of VesB (green and 
purple) and the N-terminal domain of S pilus chaperone (blue) (PDB 1L4I) 
(Knight et al, 2002). The N- and C-termini of the C-terminal domain of VesB are 
labeled. Note that the C-terminal domain of VesB has two additional β-strands 
and two additional short helices (purple).  
B. Stereo view of superposition of the C-terminal domains of VesB (green and 
purple) and cucumisin (orange) (PDB 3VTA) (Murayama et al, 2012). Pro-VesB 
contains two additional short helices (purple). 
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Interface between the protease and C-terminal domains:  
  
In the crystals, the two domains of pro-VesB interact with each other with 
a buried surface area (BSA) of 1220 Å2 (Figure 2.6B). This interface is classified 
by the PISA server as insignificant (Krissinel & Henrick, 2007), although 
physiologically relevant interfaces with the same extent of buried surface area 
have been reported (Korotkov et al, 2011). Hence, it is uncertain whether the two 
domains of pro-VesB have a different or flexible relative orientation with respect 
to each other in solution or during secretion via the T2S apparatus.  
 
Discussion: 
In this study, we show that the protease domain of VesB is related to 
trypsin in sequence, structure, and substrate specificity. Upon sequence 
alignment of trypsin and VesB, the catalytic triad and the activation site of VesB 
became apparent (Figure 2.7B). Mutating these motifs rendered VesB inactive, 
suggesting that the catalytic triad and the activation site are essential for activity, 
but have no impact on extracellular secretion of VesB (Figure 2.5). Our 
enzymatic studies suggested that VesB may preferentially cleave peptides that 
have an Arg at the P1 position and showed that VesB is inhibited by the serine 
protease inhibitors, leupeptin and benzamidine (Figures 2.2 and 2.3, Table 2.1). 
While the natural targets of VesB remains to be identified, we speculate that 
VesB may be a promiscuous protease with broad specificity as it is capable of 
cleaving both peptides and intact proteins (Figure 2.4). Lastly, the crystal 
structure revealed that the N-terminal protease domain of pro-VesB is structurally 
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homologous to mammalian trypsin of the S1A subfamily and the C-terminal 
domain contains an Ig fold (Figures 2.5-2.8).  
Bacterial serine proteases belonging to the S1A subfamily were once 
considered rare and only thought to exist in certain Streptomyces species (Rojas, 
2002; Uesugi et al, 2009). With the rapidly growing number of sequenced 
genomes, however, it is becoming increasingly clear that additional bacterial 
species also carry genes for trypsin-like enzymes. Besides the V. cholerae vesB, 
vesA and vesC, genes encoding proteases of the chymotrypsin family are also 
found in other marine Gram-negative bacteria, many belonging to the 
Vibrionaceae and Shewanellaceae families. Previously, a study was carried out 
to determine the nature of acquiring trypsin-encoding genes in bacterial 
genomes. A phylogenetic tree based on the sequence and structure of trypsins 
from various mammalian species and Streptomyces griseus revealed that these 
proteases originate from a common ancestor (Rypniewski et al, 1994). A later 
study performed a similar analysis looking at a larger selection of trypsin-like 
proteases from a variety of species, but only including a single Streptomyces 
protease as bacterial representative (Rojas, 2002). Based on the data presented 
in the latter study it is difficult to determine the evolutionary relationship between 
the trypsin-like proteases. It is not clear whether trypsin encoding genes 
originated in bacterial cells, and were maintained during subsequent evolutionary 
steps in eukaryotic species but lost in many bacterial species, or if the genes 
have been transferred horizontally between species.   
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 A way to distinguish and further analyze the relationship between the 
serine proteases of the chymotrypsin family is by determining how the activity of 
these proteases is regulated. For several trypsin-like proteases, which function in 
blood-coagulation or complement formation, activation by Na+ plays a well-
established role (Dang & Di Cera, 1996; Di Cera et al, 2007). It has been shown 
that in these proteins the residue equivalent to Tyr225 in thrombin plays a key 
role in the proper formation of the Na+-binding site (Dang & Di Cera, 1996). In 
VesB, Tyr250 is equivalent in position to Tyr225 of thrombin (Figures 2.6B and 
2.7C) and hence it would be possible that VesB is activated by sodium ions. 
However, addition of NaCl does not appear to increase purified VesB activity. In 
the crystal structure of pro-VesB no density representing a sodium ion at the 
expected position is evident, although it should be noted that the zymogen form 
of thrombin also lacks sodium (Figure 2.8D) (Pozzi et al, 2013). These results are 
not too surprising for two reasons.  
First, elegant protein engineering studies on S. griseus trypsin (SGT), 
which contains a Pro at the equivalent position of Tyr225 in thrombin and is not 
activated by Na+, have shown that up to 19 residues need to be altered, in 
addition to the Pro to Tyr change near the Na+ activation site, to obtain a SGT 
variant which is fully Na+-sensitive (Page et al, 2006). Hence, the presence of Tyr 
at the position equivalent to Tyr225 in thrombin is a necessary but not sufficient 
requirement for a member of the trypsin-like family to become activated by Na+ 
which is also supported by studies on complement mannan-binding lectin-
associated serine protease 2 (MASP-2) (Harmat et al, 2004). 
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Second, VesB is secreted and needs to function in the external milieu like 
the gut and/or aquatic habitats, sites with highly variable Na+ ion concentrations. 
For example, at aquatic environmental sites where V. cholerae is frequently 
isolated, the NaCl concentration varies between 0.2% and 3.0% (Vezzulli et al, 
2010). These conditions are quite different from that of blood, where the sodium 
ion concentration is precisely controlled. Hence, Tyr250 plays most likely a 
structural role and is not involved in Na+-activation of this V. cholerae protease. 
Taken together, our findings suggest that a tyrosine in trypsin-like proteases 
equivalent to thrombin Tyr225 cannot be used as the sole indicator of Na+ 
mediated activation. 
 The C-terminal domain of VesB is structurally similar to Ig folds of PapD-
like chaperones, subtilisin-like proteases, and several extracellular proteins from 
Vibrio. The role of the Ig fold in VesB is currently unknown; however, 
understanding the role of Ig folds in other proteins may shed light on a possible 
function of the VesB Ig fold. The PapD chaperones reside in the periplasm of 
Gram-negative bacteria and bind to type 1 pilin subunits via a donor-strand 
complementation mechanism to target them to the usher protein for outer 
membrane translocation and pilus assembly on the cell surface (Sauer et al, 
2000). The chaperone-mediated stabilization of the pilin subunits is evident in a 
papD deficient strain, in which DegP degrades the pilin subunits (Lindberg et al, 
1989; Sauer et al, 2000). The subtilisin-like serine protease cucumisin contains a 
C-terminal Ig fold domain that interacts with its catalytic domain (Murayama et al, 
2012) and in the Aeromonas sobria subtilisin-like protein ASP, the Ig fold domain 
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is located close to the active site; therefore, it has been proposed that this 
domain is involved in substrate specificity (Kobayashi et al, 2009). The Ig fold 
domain of yet another subtilisin-like protease, KP-43 from Bacillus, is suggested 
to provide stability, as KP-43 without its Ig fold domain could not be expressed 
(Nonaka et al, 2004). While the Ig fold domain may similarly provide stability to 
VesB, as we are unable to detect VesB when expressed without its C-terminal 
domain in V. cholerae, the Ig fold may alternatively, or in addition, provide 
substrate specificity although it is located relatively far (~20 Å) from the active 
site (Figure 2.6B).  
Other possible roles of the Ig fold domain may relate to the extracellular 
secretion or surface association of VesB. VesB, GbpA, ChiA, PrtV, and RbmA 
are extracellular Vibrio proteins that contain Ig fold domains (Edwin et al, 2013; 
Giglio et al, 2013; Songsiriritthigul et al, 2008; Wong et al, 2012). Some of these 
proteins (VesB, GbpA and ChiA) have been shown to utilize the T2S system for 
outer membrane translocation (Connell et al, 1998; Kirn et al, 2005; Sikora et al, 
2011). While the Ig fold domains may be involved in the transport of VesB and 
the other extracellular proteins via this translocation system, it is also possible 
that they assist in surface association of these proteins similar to the Ig fold 
domain of GbpA, which binds to the bacterial cell surface (Wong et al, 2012). 
Surface localization of VesB may optimally allow for the immediate uptake and 
intracellular delivery of peptides generated by VesB mediated proteolysis.  
In summary, we have shown that VesB has a structure and specificity 
profile resembling that of eukaryotic trypsin-like proteases. Additionally, the 
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structure of the C-terminal domain of VesB revealed an Ig fold domain that may 
be involved in one or more different functions such as stabilizing the protease 
domain, co-defining substrate specificity, binding to the bacterial surface, and 
being part of a yet undefined secretion motif of the T2S system (Korotkov et al, 
2012). 
 
Materials and Methods: 
Growth Conditions: 
All strains were grown on Luria-Bertani (LB) agar (Fisher). Single colonies 
were inoculated in Luria-Bertani (LB) broth (Fisher) with 100 µg/mL of 
carbenicillin and 1 or 100 µM isopropyl-β-D-thiogalactopyranoside (IPTG) 
(Sigma) and grown for 16 h at 37 °C.  Bacterial strains and Plasmids - The 
Vibrio cholerae strain N16961, an El Tor O1 biotype, and the isogenic ΔvesABC 
strain (Sikora et al, 2011) were used for all experiments. VesB was expressed 
from pMMB67EH-vesB (Lybarger et al, 2009), a low copy vector with an IPTG-
inducible promoter and ampicillin cassette, and pMMB67EH served as a control 
plasmid or a cloning vector for additional constructs. The QuikChange Site-
Directed Mutagenesis Kit (Agilent) was used to create vesB-S221A and vesB-
R32E with the following primers 5’-
TCATGTCAGGGAGATGCTGGTGGCCCAATTGTA-3’ (Fwd), 5’-
TACAATTGGGCCACCAGCATCTCCCTGACATGA-3’ (Rev) and 5’-
TCCACAGCAGATATTTCATCTGAAATTATTAATGGTTCGAATGCA-3’ (Fwd), 
5’-TGCATTCGAACCATTAATAATTTCAGATGAAATATCTGCTGTGGA-3’ (Rev), 
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respectively. Primers were synthesized at IDT Technologies. Restriction 
enzymes, buffers, and T4 DNA ligase were purchased from New England 
Biolabs. Plasmid constructs were transformed into Escherichia coli MC1061 and 
a triparental conjugation protocol using the helper strain, MM294, was used to 
transfer the plasmids into N16961 and ΔvesABC strains (Sikora et al, 2007).  
 
Native VesB Purification for Protease Assays: 
VesB was overexpressed in V. cholerae and culture supernatant was 
isolated and precipitated with 60% ammonium sulfate for 1 h at 4 °C. The sample 
was centrifuged at 10,000 ×g for 35 minutes at 4 °C. The pellet was suspended 
in 20 ml of 50 mM Tris-HCl, pH 8.0, 450 mM NaCl (Buffer A) and residual 
ammonium sulfate was removed through dialysis against Buffer A. The dialyzed 
sample was subjected to affinity chromatography on benzamidine-sepharose 
(GE Healthcare). The flow-through fraction was collected and the column was 
washed with Buffer A. Then, VesB was eluted using 10 ml of 100 mM 
benzamidine, 50 mM Tris-HCl, pH 8.0 buffer. Fractions were pooled and the 
buffer was exchanged to 50 mM Tris-HCl, pH 8.0 using a PD10 column (GE 
Healthcare). VesB was concentrated by ultrafiltration (30 kDa cut-off; Millipore). 
Protein concentration was determined with the Bradford assay (BioRad) using 
bovine serum albumin as a reference. Polyclonal antiserum against VesB was 
generated by Covance Inc. 
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Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and 
immunoblotting:  
Samples were prepared and analyzed via SDS-PAGE and immunoblotting 
as described previously (Sikora et al, 2007) with the following modifications. 
VesB antiserum was incubated in culture supernatants from the ΔvesABC strain 
for 1 h to pre-absorb cross-reactive antibodies prior to incubating with the 
membrane for 2 h (1:5,000 dilution) and horseradish peroxidase-conjugated goat 
anti-rabbit IgG (Biorad) was used at 1:20,000 dilution. Membranes were 
developed using ECL 2 Western blotting reagent (Thermo Scientific) and protein 
was visualized using a Typhoon Trio variable mode imager system and Image 
Quant software. SDS-PAGE gels were stained with GelCode Blue (Thermo 
Scientific) or Silver Stain Kit reagents (Invitrogen). 
 
Protease Assay: 
Protease activity in V. cholerae culture supernatants was measured using 
Boc-Gln-Ala-Arg-7-amido-4-methylcoumarin as described previously (Johnson et 
al, 2007). In other assays, supernatants were pre-incubated with benzamidine 
(Thermo Scientific) at the various concentrations listed for 10 minutes at 37 °C 
prior to measuring protease activity. Purified VesB was measured for protease 
activity with various methylcoumarin conjugated peptides (Peptides International) 
listed in Table 2.1 in a final reaction volume of 100 µl. The peptides, Suc-Ala-Ala-
Ala-AMC, Suc-(OMe)-Ala-Ala-Pro-Val-AMC, Z-Leu-Arg-Gly-Gly-AMC, Leu-AMC, 
Suc-Ala-Ala-Pro-Phe-AMC, Boc-Glu-Lys-Lys-AMC, and Boc-Gln-Ala-Arg-AMC 
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are substrates that have been successfully used for elastase, pancreatic 
elastase, isopeptidase, aminopeptidase, chymotrypsin, plasmin, and trypsin, 
respectively. All assays were done with 50 mM Tris-HCl, pH 8.0. Where stated, 
assays were performed in the presence of different concentrations of NaCl. 
Inhibition assays were done with purified VesB that was pre-incubated for 10 
minutes at 37 °C with 50 µM leupeptin (Thermo Scientific), 10 mM EDTA, or 1 
mM benzamidine. A change in fluorescence per minute was converted to moles 
of liberated 7-amido-4-methylcoumarin (AMC) per minute via a standard curve 
with known amounts of AMC. The results were then normalized by the amount of 
purified VesB or OD600 of the bacterial cultures. Standard errors were generated 
from three independent experiments each performed in three technical 
replicates. 
 
Degradation of Intact Proteins: 
 VesB concentrations ranging from 0-40 µg/mL were added to 0.781 µM of 
lactoferrin, 0.162 µM IgA, 0.015 M of casein, and 0.005 M of BSA in a 100 µL 
reaction volume. Samples were incubated for 1 hr at 37 °C, prepared and 
analyzed by SDS-PAGE and GelCode Blue staining.  
 
N-terminal Sequencing: 
Purified VesB secreted by V. cholerae was subjected to SDS-PAGE and 
transferred to a PVDF membrane using 10 mM CAPS, 10% methanol, pH 11. 
The membrane was stained with 0.025% Coomassie Brillant Blue R-250, 40% 
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methanol, 5% acetic acid solution, destained using 40% methanol, 5% acetic 
acid, washed with water and then air-dried. The VesB band was cut and 
subjected to automated Edman degradation at the protein facility core at 
University of Michigan, Ann Arbor.  
 
Statistical Analysis: 
  t tests were done on samples as indicated. Results yielding a P value of 
<0.05 were considered statistically significant.  
 
Protein expression and purification for crystallization: 
A DNA fragment corresponding to residues 24-373 of VesB was PCR 
amplified and cloned into a modified pCDF-Duet-1 vector (EMD Millipore). The 
construct contains an N-terminal pelB signal sequence and a C-terminal tobacco 
etch virus (TEV) protease cleavage site followed by a His6-tag. To overcome 
possible difficulties when overexpressing WT pro-VesB in E. coli, the Ser221 
residue was replaced with Ala using QuickChange mutagenesis protocol 
(Stratagene). The S221A variant of pro-VesB was expressed in E. coli 
Rosetta2(DE3) cells at 18 ºC for 4 h after induction with 0.5 mM IPTG. The cells 
were harvested by centrifugation and resuspended in buffer containing 20 mM 
Tris-HCl pH 7.4, 0.5 M NaCl, 1 mM PMSF, 1 mM benzamidine and 15 mM 
imidazole. Pro-VesB was purified via a Ni-NTA agarose (Qiagen) column 
followed by His6-tag cleavage with TEV protease and a second Ni-NTA agarose 
chromatography step. The yield of pro-VesB was improved from <0.5 mg to ~1.5 
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mg per 6 L of culture after addition of 2 mM Fe2+ ions to the clarified cell lysate 
(Magnusdottir et al, 2009). The final size-exclusion chromatography was 
performed using a Superose6 column (GE Healthcare) in buffer containing 20 
mM Tris-HCl pH 7.4 and 0.5 M NaCl. Pro-VesB was concentrated to 3 mg ml–1 
and flash frozen in liquid nitrogen (Deng et al, 2004).  
 
Crystallization, data collection and structure solution: 
Screening for crystallization conditions was performed using Index 
(Hampton Research) and Wizard I and II (Emerald Bio) screens. Crystallization 
trials were set-up in vapor diffusion sitting drop format (0.2 µL protein + 0.2 µL 
crystallization solution) using a Phoenix crystallization robot (Art Robbins 
Instruments). The initial crystals grew with 0.1 M HEPES pH 7.5, 3.0 M NaCl. 
The optimized crystals were obtained using a crystallization solution containing 
0.1 M Tris-HCl pH 9.0, 3.0 M NaCl (1.0 µL protein + 1.0 µL crystallization solution 
+ 0.5 µL water). Crystals were cryoprotected in crystallization solution 
supplemented with 20% glycerol and flash-cooled in liquid nitrogen.  
A 2.4 Å native dataset was collected at the Advanced Light Source, 
beamline 8.2.2. In addition, a derivative dataset was obtained in-house using a 
Saturn 94 CCD detector on a Rigaku Micromax HF-7 rotating anode from a 
crystal incubated in 0.1 M Tris-HCl pH 9.0, 2.0 M NaCl, 1.0 M NaI. Data were 
processed using HKL2000 and XDS (Kabsch, 2010; Otwinowski, 1997). The pro-
VesB structure was solved by a combination of molecular replacement and single 
wavelength diffraction methods as implemented in Phaser (McCoy et al, 2007). 
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The initial molecular replacement solution was found by using the Balbes server 
(Long et al, 2008) and the structure of MT-SP1/matriptase (PDB 1EAX) as a 
search model for the protease domain of pro-VesB (Friedrich et al, 2002; Long et 
al, 2008). 12 iodide sites were found by Phaser during the first round of phasing. 
After density modification using Parrot, model building using Buccaneer and 
iterative model improvement using Coot (Cowtan, 2006; Cowtan, 2010; Emsley 
et al, 2010), the preliminary model was submitted for the second round of 
phasing, which led to identification of 5 additional (17 total) iodide sites. 
Subsequent iterative density modification and automated model building led to an 
almost complete model that included the second domain of VesB. The model 
was improved using Coot and refined using REFMAC5 and 9 
translation/libration/screw (TLS) groups identified by the TLSMD server 
(Murshudov et al, 2011; Painter & Merritt, 2006). The quality of the model was 
assessed using Coot and the MolProbity server (Chen et al, 2010). Residues 32-
372 are included in the final model, while residues 166-172, 214-217 and 244-
247 had poorly defined density and were not modeled. The final model includes 
93 water molecules and has good geometry with 97.5% residues in the favorable 
areas of the Ramachandran plot (Table 2.2). The atomic coordinates and 
structure factors for pro-VesB (code 4LK4) have been deposited in the Protein 
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Chapter 3: 
 
A novel protein sorting mechanism for cell 






Vibrio cholerae and a subset of other Gram-negative bacteria express 
proteins with C-terminal tripartite transmembrane domains called GlyGly-
CTERM, which consist of a motif rich in glycines and serines, followed by a 
hydrophobic region and positively charged residues. Here we show that VesB, a 
V. cholerae serine protease containing a GlyGly-CTERM domain, requires both 
the type II secretion system and a rhomboid-like protease for localization at the 
cell surface. The rhomboid-like protease, rhombosortase, cleaves the GlyGly-
CTERM domain and promotes surface retention possibly through transamidation 
and linkage of VesB to a membrane component. In support of this, cell-
associated VesB activity is no longer detected when the rhombosortase gene is 
inactivated or when VesB is expressed without its GlyGly-CTERM domain. 
Instead, the GlyGly-CTERM deleted VesB is released to the extracellular milieu, 
while in the absence of GlyGly-CTERM processing, wild-type VesB is inactive 
and unstable. We propose that the rhombosortase/GlyGly-CTERM system is the 
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Gram-negative equivalent of the sortase/LPXTG system in Gram-positive 
bacteria, which anchors surface proteins to the cell wall through transpeptidation. 
 
Introduction: 
The type II secretion (T2S) system is a multi-protein complex used by 
many Gram-negative bacteria to secrete extracellular proteins (Cianciotto, 2005; 
Korotkov et al, 2012). Most notably, Vibrio cholerae, the causative agent of 
cholera, uses the T2S system to secrete cholera toxin (Sandkvist et al, 1993). 
Cholera toxin and other T2S substrates are secreted in a two-step process. First, 
proteins translocate to the periplasmic compartment via recognition of their signal 
peptide by the Sec system. Then, the periplasmic secretion intermediates fold 
and engage with the T2S system for outer membrane translocation. These 
substrates are then free to diffuse away from the cell (Sandkvist, 2001). 
However, some substrates that utilize the T2S system have been found to be 
cell-associated. The heat-labile enterotoxin of enterotoxigenic Escherichia coli 
(ETEC); pullulanase, a lipoprotein from Klebsiella oxytoca; the Dickeya dadantii 
pectin lyase, PnlH; and the Shewenella oneidensis c-type cytochrome, OmcA, 
are first transported across the cell envelope by the T2S system and then 
associate with the cell surface (Donald et al, 2008; Ferrandez & Condemine, 
2008; Horstman & Kuehn, 2002; Pugsley et al, 1986; Rondelet & Condemine, 
2013).  
In addition to cholera toxin, V. cholerae transports a number of other 
proteins, including three serine proteases, VesA, VesB and VesC, across the 
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outer membrane via the T2S system (Sandkvist et al, 1997; Sikora et al, 2011). 
VesB, the focus of this paper, is a trypsin-like serine protease that contains an N-
terminal signal peptide, a protease domain, and an immunoglobulin-fold domain 
(Gadwal et al, 2014). The protease domain is 30% homologous to trypsin and 
includes a typical His-Asp-Ser catalytic triad and activation site. VesB is made as 
a zymogen and cleavage at the activation site (Arg32-Ile33) results in the 
removal of the N-terminal propeptide to generate active VesB (Gadwal et al, 
2014). VesB, along with five other V. cholerae proteins, VesC, VesA, a putative 
metalloprotease (VCA0065), a hypothetical protein (VC1485), and a nuclease, 
Xds, also contain a C-terminal domain called GlyGly-CTERM (Haft & Varghese, 
2011) (Figure 3.1).  
 
Figure 3.1: Alignment of GlyGly-CTERM containing proteins in V. cholerae. 
The primary sequences of the C-terminal portions of the six proteins in V. 
cholerae containing the GlyGly-CTERM domain are aligned based on the GlyGly-
CTERM sequence logo in (Haft & Varghese, 2011). The region rich in glycines 
and serines, the hydrophobic residues, and the positively charged residues are 
underlined. 
 
Predicted to be a transmembrane domain, the GlyGly-CTERM has a 
consensus tripartite motif that contains two prominent glycines surrounded by 
serines, followed by a hydrophobic helix and positively charged residues (Figure 
3.1). Thus far, only a few GlyGly-CTERM proteins have been characterized and 
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their subcellular location has not been fully determined. While the GlyGly-
CTERM containing ExeM is found as an active endonuclease in the culture 
supernatant of S. oneidensis (Godeke et al, 2011), proteomic studies of 
membranes have identified ExeM as a membrane-associated protein (Brown et 
al, 2010; Tang et al, 2007). Xds, an ExeM homolog, displays a similar distribution 
as Xds nuclease activity has been detected in both culture supernatant and cells 
(Newland et al, 1985; Seper et al, 2011). Although these dual locations may 
seem contradictory, they may be the result of a sustained, slow, cellular release 
from the T2S system. Alternatively, the cell surface may be the primary location 
of these enzymes and membrane-association may involve their GlyGly-CTERM 
domain. The novel GlyGly-CTERM domain was originally identified 
bioinformatically in Gram-negative bacteria of the Vibrio, Shewanella, 
Acinetobacter and Ralstonia genera (Haft & Varghese, 2011). Through in silico 
partial phylogenetic profiling, proteins that have the GlyGly-CTERM domain were 
identified to co-exist with rhombosortases, a subfamily of rhomboid proteases 
(Haft & Varghese, 2011).  
Rhombosortase is homologous to rhomboid proteases, a class of 
membrane-embedded serine proteases that contain a Ser-His active site located 
within the lipid bilayer (Ben-Shem et al, 2007; Lemieux et al, 2007; Wang et al, 
2006; Wu et al, 2006). Crystallography studies of the rhomboid protease, GlpG, 
indicate that it is comprised of six transmembrane domains, with a deep cavity 
within its folded form that contains the active catalytic dyad (Ben-Shem et al, 
2007; Lemieux et al, 2007; Wang et al, 2006; Wu et al, 2006). Rhomboid 
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proteases are nearly ubiquitous and function in a wide range of processes 
(Freeman, 2008) (Rather, 2013). In bacteria, only one substrate has been 
identified, the channel-forming TatA of the twin-arginine translocation (TAT) 
system. The Providencia stuartii rhomboid protease, AarA, cleaves and thereby 
activates TatA, which results in the formation of the TAT system (Fritsch et al, 
2012; Stevenson et al, 2007). Rhomboid proteases typically cleave substrates 
with a single transmembrane domain that contains helix-destabilizing residues, 
such as prolines and glycines. Cleavage preferably occurs at small residues such 
as alanine within the transmembrane helix of substrates (Akiyama & Maegawa, 
2007; Strisovsky et al, 2009). 
The presence of helix destabilizing residues in the putative 
transmembrane helix of the GlyGly-CTERM domain in VesB and other substrates 
suggests that they may be cleaved by rhombosortase (Haft & Varghese, 2011). 
Because of the similarity of the GlyGly-CTERM domain and the Gram positive 
tripartite C-terminal LPXTG sorting motif that is cleaved and covalently cell wall 
anchored by sortase in Gram positive cells (Mazmanian et al, 1999; Schneewind 
et al, 1992), we hypothesize that rhombosortase may similarly cleave and anchor 
GlyGly-CTERM proteins to the cell envelope of Gram negative bacteria. 
In this study, we address the role of rhombosortase, the T2S system, and 
the GlyGly-CTERM domain on proteins by using VesB as a model protein. Here 
we show that VesB is distributed in a pattern similar to the nucleases, ExeM and 
Xds, in that VesB has both secreted and surface-associated activities. Analysis 
of the localization and activity of VesB in different mutant backgrounds reveals 
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that rhombosortase cleaves VesB and promotes T2S-dependent cell retention 
and activity of VesB.  
 
Results: 
Cell-associated VesB is active: 
Previously, we have shown that V. cholerae produces three related 
extracellular serine proteases, VesA, VesB and VesC, of which VesB contributes 
to the majority of activity (data not shown, Sikora et al, 2011).  While VesB is a 
type II secreted protease with its N-terminal signal peptide and propeptide 
removed, a large fraction of VesB remains cell-associated (Gadwal et al, 2014; 
Sikora et al, 2011). To determine whether the cell-associated form is also active, 
we expressed plasmid-encoded VesB in a strain lacking the three related vesA, 
vesB and vesC genes (ΔvesABC; [16]). We included two additional strains, one 
containing an empty vector and one expressing an active site mutant protein, 
VesB-S221A, to serve as negative controls. Cultures were grown in the presence 
of 50 µM IPTG in LB for 4 hours, after which culture supernatants and cells were 
separated by centrifugation and the VesB activity was analyzed using two 
different approaches. When using the fluorogenic peptide, Boc-Gln-Ala-Arg-
AMC, active VesB, but not VesB-S221A, was found in both the culture 
supernatant and cells (Figure 3.2A). Similarly, when using the fluorophosphonate 
probe, ActivX TAMRA-FP, which covalently labels the serine residue in the active 
sites of serine hydrolases (Patricelli et al, 2001), we found that the probe bound 
to the WT form of VesB both in the culture supernatant and cells as visualized by 
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SDS-PAGE and fluorescent gel imaging (Figure 3.2B, top panel). While VesB-
S221A was recognized by VesB antibodies (Figure 3.2B, bottom panel), it could 
not be detected with ActivX TAMRA-FP; highlighting the specificity of the probe 
(Figure 3.2B, top panel). Collectively, the results from the two assays suggest 
that both the secreted and cell-associated forms of VesB are active. Like other 
trypsin-like proteases, VesB is produced as a zymogen and removal of the 
propeptide results in active VesB (Gadwal et al, 2014). The finding that VesB-
S221A migrated slower compared to VesB when analyzed by SDS-PAGE and 
immunoblotting indicated that it still contains the propeptide and suggests that 
VesB is an autoactivating enzyme (Figure 3.2B, bottom panel).  
 
Figure 3.2: Secretion profile of VesB in V. cholerae. The ΔvesABC strain 
containing empty vector (p), pVesB, or pVesB-S221A were grown in LB with 100 
µg/mL carbenicillin and 50 µM IPTG for four hours. Samples were separated into 
supernatants (S) and cells (C). The experiments were done in biological 
triplicates and standard error bars are shown.  
A.  Secreted and cell-associated VesB are active. Serine protease activity 
against a fluorogenic peptide, Boc-Gln-Ala-Arg-AMC, was measured in 
culture supernatants and cells.  
B.  ActiveX-TAMRA probe binds to both secreted and cell-associated VesB. 
The culture supernatants and cells were incubated with the ActiveX-
TAMRA serine hydrolase probe followed by SDS-PAGE and fluorescent 
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imaging using the Typhoon imager system (top panel) or subjected to 
SDS-PAGE and immunoblotting with VesB antibodies (bottom panel).  
 
  
VesB is cell surface-associated: 
Because we detected cell-associated VesB activity, we hypothesized that 
VesB may be surface-localized in T2S competent cells, but remains internally 
trapped in T2S mutant cells (Δeps). To test this, we expressed plasmid-encoded 
VesB in ΔvesB and ΔvesBΔeps strains and subjected the cells to labeling with 
anti-VesB antibodies and Alexa Fluor 488 F(ab′)2 goat anti-rabbit IgG. In this set 
of experiments, the cultures were grown in M9 medium supplemented with 
glucose and casamino acids to avoid autofluorescence observed with LB grown 
cells. Under this growth condition, the majority of VesB protein and activity was 
cell-associated in the ΔvesB/pVesB strain; very little VesB was found in the 
culture supernatant (Figure 3.3AB). While all of VesB remained cell-associated in 
an inactive form in the ΔvesBΔeps/pVesB strain, occasionally a very small 
amount of inactive VesB can be detected in the culture supernatant (Figure 
3.3AB). VesB migrated slower in ΔvesBΔeps than ΔvesB, perhaps indicating the 
presence of the N-terminal propeptide in the absence of the T2S system; thus 
suggesting that activation of VesB may occur after translocation through the 
outer membrane.  For the VesB labeling experiment, the ΔvesB and ΔvesBΔeps 
strains with empty vector served as negative controls. After thorough washing, 
the cells were visualized by fluorescence microscopy (Figure 3.3C). While 
circumferential fluorescent foci were observed for 94% of ΔvesB/pVesB cells, no 
fluorescent foci were revealed on ΔvesBΔeps/pVesB mutant cells. The labeling 
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efficiency was quantitated by fluorimetry and the fluorescent units were 
normalized to OD600 of the original cultures. The fluorescence measured for 
ΔvesB/pVesB was 4.8-fold higher when compared to ΔvesBΔeps/pVesB, 
suggesting that VesB is surface-localized in WT cells, while it primarily remains 
intracellular in the Δeps cells (Figure 3.3D). Taken together, our results suggest 
that outer membrane translocation by the T2S system is required for VesB 
localization to the surface of WT cells. 
 
Figure 3.3: VesB is surface-associated in WT but not in the T2S mutant. The 
ΔvesB and ΔvesBΔeps strains containing empty vector (p) or pVesB were grown 
for four hours in M9 media supplemented with glucose and casamino acids in the 
presence of 100 µg/mL carbenicillin and 50 µM IPTG. All experiments were done 
in triplicates and standard error bars are shown. 
A. The majority of VesB activity is cell-associated in T2S competent cells. 
Supernatants (S) and whole cells (C) were isolated and analyzed for 
protease activity using a fluorogenic peptide, Boc-Gln-Ala-Arg-AMC. 
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B.  The majority of VesB is cell-associated. Samples from A were analyzed by 
SDS-PAGE and western blotting for the protein levels of VesB.   
C.  Detection of VesB on the surface of T2S competent cells. Cells were 
washed and incubated with VesB antibodies followed by AlexaFluor 488 
antibodies. Labeled cells were visualized by fluorescence microscopy.  
D.  Quantitative measurements indicate the presence of cell surface VesB in 
T2S competent cells. Cells that were labeled with VesB antibodies and 
AlexaFluor 488 antibodies were subjected to quantitative fluorimetry. The 
fluorescence units were normalized by OD600 of the original cultures and 
fold changes over cells with empty vector were calculated. The 
experiments were done in triplicates and standard error bars are shown. p 




Rhombosortase-mediated processing of VesB:  
The above experiments showed that the T2S system is responsible for 
outer membrane translocation of VesB; however, they did not provide an 
explanation for the relatively large amount of surface retained VesB and why only 
a small amount of VesB is released to the culture supernatant. Therefore, in the 
next set of experiments we determined whether surface retention of VesB 
involves the putative transmembrane domain, GlyGly-CTERM, and/or its possible 
removal by the rhombosortase protease, RssP. We postulated that by using 
VesB-S221A, which does not undergo autoactivation (Figure 3.2B), we could 
ascribe any size changes of VesB to C-terminal processing, possibly involving 
the removal of the GlyGly-CTERM domain. Cultures of ΔvesB/pVesB-S221A, 
ΔvesBΔeps/pVesB-S221A and rssP::kan/pVesB-S221A, in which the 
rhombosortase (rssP) gene is inactivated, were grown in the presence of 50 µM 
IPTG in M9 media supplemented with glucose and casamino acids. Culture 
supernatants and cells were separated and size differences of VesB-S221A were 
	   71	  
analyzed by SDS-PAGE and western blotting (Figure 3.4). We found that VesB-
S221A was unstable in the absence of rhombosortase, thus we loaded ten times 
less of the cell extracts containing a functional rhombosortase (Figure 3.4, lanes 
2, 10 and 12) to clearly visualize potential size differences of VesB-S221A in the 
various mutants.  
 
Figure 3.4: Cleavage of VesB by rhombosortase. The indicated mutant strains 
with pVesB-S221A were grown for four hours in M9 media supplemented with 
casamino acids, glucose, 100 µg/mL carbenicillin and 50 µM IPTG. Culture 
supernatant (S) and cells (C) were isolated, matched by equivalent OD600 units 
(except for the cell samples of the ΔvesABC, ΔglpGΔeps, and ΔvesBΔeps 
strains which were diluted 1:10) and analyzed by SDS-PAGE and western 
blotting with VesB antibodies.  
 
As expected, VesB-S221A was processed in the ΔvesB and ΔvesBΔeps 
mutant strains, in which rhombosortase is present. When the rhombosortase 
gene was inactivated (rssP::kan), a portion of VesB-S221A migrated slower than 
VesB-S221A in the ΔvesB cells (Figure 3.4, compare lanes 2 and 4). This form of 
VesB-S221A was exclusively detected in the cell fraction (Figure 3.4, lane 4). 
Interestingly, a small amount of VesB-S221A was still cleaved and secreted 
extracellularly (Figure 3.4, lane 3). This cleaved form was no longer released 
when the T2S system was inactivated in the rssP::kanΔeps double mutant 
(Figure 3.4, lane 5). While these results suggested that rhombosortase likely 
cleaves off the GlyGly-CTERM domain or some part thereof in the ΔvesB and 
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ΔvesBΔeps cells, there was no explanation for the residual processing of VesB-
S221A in the absence of rhombosortase. As V. cholerae encodes a homologous 
rhomboid protease, GlpG, with which rhombosortase shares 19% amino acid 
sequence identity, we hypothesized that GlpG is responsible for cleaving a 
fraction of VesB-S221A in the rssP::kan mutant. To test this, we made a double 
mutant, where both protease genes glpG and rssP were inactivated 
(rssP::kanΔglpG). In this background, VesB-S221A remained associated with the 
cells in an un-processed form suggesting that GlpG is capable of cleaving VesB-
S221A, albeit inefficiently, when rhombosortase is absent (Figure 3.4, lane 8). As 
VesB-S221A was completely cleaved in the ΔepsΔglpG double mutant in which 
the rhombosortase gene remains intact, it suggests that rhombosortase is most 
likely the protease that cleaves the GlyGly-CTERM domain (Figure 3.4, lanes 9 
and 10). The latter result also indicates that rhombosortase-mediated processing 
of VesB does not require the presence of a functional T2S apparatus and 
suggests that cleavage normally occurs before VesB engages the T2S system. 
Taken together, rhombosortase cleaves the GlyGly-CTERM domain of VesB and 
likely promotes surface retention, as the majority of VesB remains cell-associated 
and can be detected on the surface of WT cells (Figures 3.3 and 3.4).   
 
C-terminal processing by rhombosortase is a prerequisite for VesB 
autoactivation:  
To establish the functional consequences of C-terminal processing of 
VesB, we next analyzed WT VesB expressed from its native promoter. 
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Specifically, we wanted to determine whether N-terminal processing and 
activation of VesB is dependent on C-terminal modification by rhombosortase. 
Cultures were grown in LB and culture supernatants and intact cells were 
analyzed for VesB activity and location by immunoblotting. In both WT and ΔglpG 
strains, VesB was active in the culture supernatants and cells (Figure 3.5A), and 
the size and distribution of VesB were the same according to immunoblot 
analysis (Figure 3.5B, lanes 2, 4, 9 and 11), suggesting that GlpG does not play 
a significant role in the localization or activation of VesB when rhombosortase is 
present. In the experiment shown in Figure 3.4, VesB-S221A was unstable and 
detected in two forms when overexpressed in the rssP::kan mutant and only the 
GlpG-cleaved form was found in the culture supernatant. Here, when VesB was 
expressed from its native promoter in the rssP::kan mutant it was only detected 
in the culture supernatant (Figure 3.5B, compare lanes 3 and 10). VesB in the 
rssP::kan mutant was inactive (Figure 3.5A) and migrated slower than VesB in 
the WT strain (Figure 3.5B; compare lanes 3 and 4) indicating that the GlpG-
cleaved form of VesB does not undergo autoactivation. Furthermore, the VesB 
species that retained the GlyGly-CTERM extension could not be detected in cells 
expressing native VesB in the rssP::kan mutant (Figure 3.5B, lane 10), again 
suggesting that un-cleaved VesB is unstable and prone to degradation.  
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Figure 3.5: Native VesB is slightly larger, secreted, and inactive in the 
rhombosortase mutant. WT and the indicated mutants containing empty vector 
(p), pRssP, pRssP-S102A or pRssP-H160A were grown for 4 hours in LB broth 
with 100 µg/mL carbenicillin and 10 µM IPTG. Culture supernatants (S) and 
whole cells (C) were isolated and analyzed.  
A.  VesB is inactive in the rhombosortase mutant. Protease activity of VesB 
was measured using a fluorogenic peptide, Boc-Gln-Ala-Arg-AMC. All 
experiments were done in triplicates and standard error bars are shown. 
The difference in activity of VesB in the WT strain was statistically 
significant (p<0.01**) when compared to the activity of VesB in the other 
samples except for ΔglpGp and rssp::kan pRssP supernatants and cells. 
VesB activity in rssP::kan/p strain was not statistically significant when 
compared to the activity of VesB in the rhombosortase mutant 
complemented with the point mutants.  
B.   VesB migrates slower in the supernatant of the rhombosortase mutant. 
VesB protein in supernatants (S) and cells (C) were analyzed by SDS-
PAGE and immunoblotting with VesB antibodies.   
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When the rssP::kan mutant was complemented with the plasmid pRssP, 
we observed partial restoration of VesB activity in the culture supernatant and 
cells (Figure 3.5A) and the same migration and localization pattern as that of 
VesB in the WT strain (Figure 3.5B, lanes 5 and 12). In addition, the overall 
amount of VesB protein increased (Figure 3.5B, lanes 5 and 12 compared to 3 
and 10). No complementation of the rssP::kan mutant was apparent in the 
presence of pRssP-S102A and pRssP-H160A, which express mutant forms of 
rhombosortase in which the predicted catalytic residues serine and histidine, 
respectively, are substituted with alanine (Figure 3.5A and B, lanes 6, 7, 13 and 
14). Furthermore, VesB was found only in the cells and had no activity in the 
rssP::kanΔeps double mutant, suggesting that VesB found in the supernatant of 
the rssP::kan strain utilized the T2S system for extracellular transport (Figure 
3.5A and B, lanes 1 and 8). Taken together, while active VesB is primarily 
associated with the surface of WT cells, with a smaller amount of active VesB 
released to the culture supernatant, VesB is only found in the culture supernatant 
in an inactive larger form in the absence of rhombosortase. 
 
The propeptide of VesB is not removed in the rssP::kan mutant: 
The larger size and lack of activity of VesB in the culture supernatant of 
the rssP::kan mutant suggested that GlpG-cleaved VesB does not undergo 
autoactivation. To further test this hypothesis, we took a proteomics approach 
that involved isolating and concentrating the culture supernatants of the WT and 
rssP::kan strains and subjecting them to off-line SDS-PAGE, gel segmentation, 
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in-gel digestion with trypsin, and LC/MS/MS. Many proteins were identified using 
this method, however, we focused on the GlyGly-CTERM domain containing 
proteins. Peptide mapping gave a VesB sequence coverage of 55% in the WT 
sample (Figure 3.6A). In the rssP::kan sample, which gave a sequence coverage 
of 57%, the N-terminal VesB peptide, ESTADISSR representing the propeptide 
of VesB, was present (Figure 3.6A). This peptide was absent in VesB from the 
WT sample, a finding that was also obtained through N-terminal sequencing of 
purified VesB (Gadwal et al, 2014). The presence of the propeptide of VesB in 
the rssP::kan mutant explains the larger size and the lack of activity of VesB in 
this mutant (Figure 3.5). Additionally, similar analysis of another GlyGly-CTERM 
containing trypsin-like protease, VesC, which resulted in 75 and 62% sequence 
coverage for the WT and rssP::kan mutant, respectively, revealed that the 
propeptide was also present on VesC when rhombosortase is absent (Figure 
3.6B). In summary, C-terminal cleavage by rhombosortase is a prerequisite for 
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Figure 3.6: The propeptide is present in VesB and VesC in the 
rhombosortase mutant. Peptide mapping of VesB and VesC by mass 
spectrometry analysis of culture supernatants of WT and rhombosortase mutant 
(rssP::kan) strains. The yellow areas denote peptide coverage and the 
underlined sequence represents the N-terminal propeptide.  
A. The peptide coverage of VesB.  
B. The peptide coverage of VesC. 
 
The lack of peptide coverage for the GlyGly-CTERM domain of VesB in 
the WT and rssP::kan samples supports the results presented in figure 3.4, which 
showed that VesB is cleaved by rhombosortase in WT cells and partially by GlpG 
in rssP::kan samples. The proteomics data of the rssP::kan sample identified a 
C-terminal VesB peptide, IQLDTSPFAPSASSGG, suggesting that VesB may be 
cleaved by GlpG at Gly383Ser384 resulting in the removal of most of the GlyGly-
CTERM domain in the rssP::kan mutant (Figure 3.6A). The mechanism by which 
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VesB is released from the surface in WT cells is not known; however, the 
detection of the C-terminal peptide, IQLDTSPFAPSAS, in the WT sample 
suggests that release may occur through cleavage by a protease at Ser380 and 
Ser381 (Figure 3.6A). Alternatively, the linking of VesB to the membrane may be 
inefficient and a fraction of VesB may undergo complete hydrolysis following 
rhombosortase-mediated cleavage resulting in its release from the surface. If this 
is the case, Ser380-Ser381 may represent the site of rhombosortase processing. 
The lack of peptide coverage for the GlyGly-CTERM domain in VesC is also 
suggestive of C-terminal processing in the WT and rssP::kan mutant samples 
(Figure 3.6B). Unfortunately, trypsin cleaves very close to the GlyGly-CTERM 
domain and may have generated a peptide that was too small to be resolved in 
these experiments.    
 
Reduction in amounts of other GlyGly-CTERM proteins in the absence of 
rhombosortase:  
The proteomic data were also used to compare the amount of VesB and 
the other five GlyGly-CTERM containing proteins in the culture supernatant of the 
WT and rssP::kan strains. Spectral counts for each protein were normalized to 
total number of spectra in each sample and protein size to obtain Normalized 
Spectral Abundance Factor (NSAF) values for each protein in the two samples 
(Table 3.1). We hypothesized that the amount of these proteins would be 
reduced in the culture supernatant of the rssP::kan mutant unless some of the 
other proteins are also cleaved by GlpG in the absence of rhombosortase. The 
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results showed that the amount of VesC and VCA0065 were significantly 
reduced by four-fold or more, while VesA and Xds were not detected in the 
absence of RssP (Table 3.1). Consistent with results from our immunoblotting 
experiments, VesB was only reduced by a factor of 1.5 in the rssP::kan mutant, 
while the level of VC1485 was increased by a factor of 2. However, the results for 
VesB and VC1485 were not statistically significant, likely due to GlpG’s ability to 
cleave and thus release VesB and perhaps also VC1485 to the culture 
supernatant.  
 
Table 3.1: Four of the six GlyGly-CTERM domain containing substrates are 











VCA0065 29 20 0.0023 0.0004 5.4 
VesC 67 59 0.0127 0.0026 4.9 
Xds 33 0 0.0015 0 - 
VesA 11 0 0.0015 0 - 
VesB 49 50 0.0023 0.0015 1.5 
VC1485 59 67 0.0062 0.0125 0.5 
 
*A ratio of ≤ 4 is considered statistically significant 
 
 
The GlyGly-CTERM domain is required for surface retention of VesB: 
To determine the functional consequences of expressing VesB without an 
intact GlyGly-CTERM domain on VesB localization and activity, two VesB 
variants, VesBΔ5 and VesBΔ30 were constructed. VesBΔ5 has the positively 
charged residues at the C-terminus removed and VesBΔ30 has the additional 
Gly/Ser rich motif and hydrophobic region removed. These constructs and VesB 
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were expressed in ΔvesABC cells and at various time points, culture 
supernatants and cells were collected and analyzed for VesB localization and 
activity. While VesBΔ5 displayed a slightly higher activity than VesB in the culture 
supernatant (Figure 3.7A), no cell-associated activity could be detected (Figure 
3.7B). No VesBΔ30 activity was detected in any fraction, except for low activity 
observed in the 8.5h culture supernatant sample (Figure 3.7A). The total 
combined activity in supernatants and cells of VesBΔ5 and VesBΔ30 was lower 
than the total activity in supernatants and cells of VesB, suggesting that both 
VesBΔ5 and VesBΔ30 are unstable. The blots correlated well with the activity 
assays in that VesB was present in the culture supernatant and cells, while 
VesBΔ5 was found mostly in the supernatant with a small amount cell-
associated, and VesBΔ30 was detected exclusively in the supernatant (Figure 
3.7C). The reduction in total amounts of protein and activity of VesBΔ5 and 
VesBΔ30 in comparison to VesB suggests that without the GlyGly-CTERM 
domain, VesB is unstable. More importantly, however, is the finding that the 
presence and the subsequent removal of the GlyGly-CTERM domain by 
rhombosortase are essential for the cell surface retention of VesB. In summary, 
the GlyGly-CTERM domain and the processing by rhombosortase are 
prerequisites for surface retention of VesB.  
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Figure 3.7: VesB is not retained on the cell surface when produced without 
the GlyGly-CTERM domain. A-C. Cultures of indicated strains expressing VesB 
or C-terminally deleted VesBΔ5 and VesBΔ30 were grown in LB broth with 100 
µg/mL carbenicillin and 40 µM IPTG. Samples were collected at time points 
indicated and separated into culture supernatant (S) and cells (C). All 
experiments were done in triplicates and standard error bars are shown. p values 
were generated by comparing culture supernatants and cells containing VesB to 
those having VesBΔ5 and VesBΔ30. These were all statistically significant at the 
4 - 8.5 hour time points in both supernatants and cells, except for VesB and 
VesBΔ5 at the 7 hour supernatant time point.  
A. VesB and VesBΔ5 are active in culture supernatants. Using the 
fluorogenic peptide, Boc-Gln-Ala-Arg-AMC, the activity of VesB, VesBΔ5 
and VesBΔ30 was measured in culture supernatants. 
B. No surface-associated protease activity in cells producing GlyGly-CTERM 
domain mutants. The activity of VesB, VesBΔ5 and VesBΔ30 was 
measured in cells as in A.  
C.  VesB is not cell-associated in the absence of the GlyGly-CTERM domain. 
The culture supernatants (S) and cells (C) were subjected to SDS-PAGE 
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Cell-associated VesB can be extracted with Triton X-100: 
Next, we determined the localization of VesB prior to engagement with the 
T2S system. Specifically, we wanted to know whether VesB accumulates as a 
periplasmic intermediate or a membrane intermediate in a T2S mutant. A 
common approach is to separate the inner and outer membrane by density 
centrifugation following cell lysis of bacteria such as E. coli and Salmonella, 
however, attempts to separate V. cholerae membranes have been unsuccessful. 
Therefore, we performed subcellular fractionation of WT and ΔepsD strains 
expressing plasmid-encoded Green Fluorescent Protein (pGFP) using a protocol 
that involves selective extraction of membrane proteins using a non-ionic 
detergent. The cells (C) were lysed using sucrose/lysozyme/EDTA and 
sonication followed by centrifugation to separate the soluble fraction (containing 
periplasmic and cytoplasmic proteins, P/C) from the membrane fraction. The 
membrane fraction was then treated with Triton X-100 and the samples were 
centrifuged to separate the triton soluble fraction (inner membrane proteins, IM) 
from insoluble material (outer membrane proteins, OM). The fractions were 
analyzed using SDS-PAGE and immunoblotting. Cytoplasmic GFP, inner 
membrane protein EpsL, and outer membrane protein OmpU were used as 
fractionation controls, as they are found in the soluble fraction, Triton X-100 
soluble fraction, and Triton X-100 insoluble fraction, respectively (Figure 3.8A). 
VesB was mostly found in the Triton X-100 soluble fraction in the T2S mutant 
(Figure 3.8A), suggesting that VesB likely enters the T2S system as an inner 
membrane intermediate and may never enter the periplasmic compartment as a 
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soluble protein. Surprisingly, VesB was also predominantly detected in the Triton 
X-100 soluble fraction in WT cells suggesting that VesB remains tethered to the 
inner membrane, while exposed on the cell surface. Alternatively, VesB is 
localized in the outer membrane of WT cells in a Triton X-100 extractable form. 
The retention in the inner (or outer) membrane of rhombosortase-cleaved VesB 
may be due to additional post-translational modification, possibly through 
transamidation, of the new VesB C-terminus.    
 
Figure 3.8: VesB is localized to the inner membrane prior to its engagement 
with the T2S system. Subcellular fractionation of cells was done as described in 
Material and Methods. Cells (C) were separated into a soluble fraction containing 
periplasmic and cytoplasmic proteins (P/C) and membrane fraction. The 
membrane was further fractionated into Triton X-100 soluble and insoluble 
fractions containing inner (IM) and outer membrane (OM) proteins, respectively. 
A.  Subcellular fractionation of WT and T2S mutant cells. Cells of WT and 
epsD mutant strains expressing plasmid encoded GFP were grown for 
four hours in LB with 100 µg/mL carbenicillin and 10 µM IPTG. Samples 
were analyzed by SDS-PAGE and immunoblotting with antibodies directed 
against VesB, GFP, EpsL, and OmpU.  
B.  Mutants of the GlyGly-CTERM domain are found in the soluble fraction. 
Subcellular fractions of a T2S mutant expressing WT and GlyGly-CTERM 
modified VesB. Samples of ΔepsΔvesB carrying pVesB and pVesBΔ5 
were diluted 1:10 while the empty vector and pVesBΔ30 samples were 
undiluted and analyzed by SDS-PAGE and immunoblotting with VesB 
antiserum.  
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As VesBΔ30 and VesBΔ5 were predominantly released to the 
extracellular space and none or only a small amount of protein was detected in 
the cell samples, respectively (Figure 3.7), we predicted that these VesB variants 
are primarily secreted via a soluble periplasmic intermediate similar to cholera 
toxin (Hirst & Holmgren, 1987b). To test this, the T2S mutant (ΔepsΔvesB) cells 
overexpressing VesB, VesBΔ5, and VesBΔ30 were subjected to subcellular 
fractionation. As shown in figure 3.8B, VesB was mostly found in the Triton X-100 
soluble fraction in the ΔepsΔvesB/pVesB strain. In contrast, VesBΔ5 was found 
in the soluble fraction containing periplasmic and cytoplasmic proteins and the 
Triton X-100 soluble fraction, while VesBΔ30 was found exclusively in the soluble 
fraction (Figure 3.8B). Taken together with findings presented above, these 
results suggest that VesB is capable of engaging the T2S apparatus whether it is 
tethered to the membrane or soluble in the periplasm. They also suggest that the 
location of VesB prior to its engagement with the T2S system dictates the final 
location of VesB. When VesB is transported by the T2S system from a 
membrane location, it will primarily remain surface-associated, while transport 




In this study, we used the trypsin-like serine protease VesB as a model 
protein to determine the relationship between the GlyGly-CTERM domain, 
rhombosortase, and the T2S system in V. cholerae. T2S substrates translocate 
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through the outer membrane and are either released into the extracellular milieu 
or retained on the cell surface through a variety of mechanisms. We show here 
that the majority of VesB is surface-associated; however, depending on growth 
conditions, various amounts of the surface retained VesB are released to the 
extracellular space (Figures 3.2 and 3.3). While many T2S substrates are found 
as soluble periplasmic secretion intermediates prior to their engagement with the 
T2S system, VesB is likely found in the inner membrane or possibly in a Triton X-
100 extractable form in the outer membrane (Figure 3.8). Rhombosortase 
cleaves off the GlyGly-CTERM domain and may further modify the newly 
generated C-terminus in order to retain VesB on the cell surface once 
transported through the T2S system (Figures 3.3-3.5). When rhombosortase is 
absent, GlpG inefficiently cleaves the GlyGly-CTERM domain, however, in this 
case there is likely no additional post-translational modification and VesB is 
released to the extracellular milieu (Figures 3.4 and 3.5). Additionally, 
rhombosortase-mediated C-terminal processing subsequently leads to VesB 
activation, while cleavage by GlpG results in an inactive VesB that retains its N-
terminal propeptide (Figure 3.6).  
Taking all of the data together, we have assembled a model for successful 
delivery of VesB to the cell surface of V. cholerae that involves its GlyGly-
CTERM domain, rhombosortase and the T2S system (Figure 3.9). VesB is 
synthesized in the cytoplasm with an N-terminal signal peptide and a C-terminal 
GlyGly-CTERM domain (1). VesB enters the Sec system via the signal peptide 
and, as the protein is translocated through the Sec system, the GlyGly-CTERM 
	   86	  
domain is positioned in the inner membrane (2). The signal peptide is cleaved off 
(3) and VesB folds (4). Rhombosortase cleaves the GlyGly-CTERM domain (5) 
and possibly further modifies the new VesB C-terminus to prevent its release to 
the periplasmic compartment (6). VesB enters the T2S system to be delivered to 
the cell surface (7). Under some growth conditions, a fraction of VesB is then 
released from the cells with an as yet unknown mechanism. In the absence of 
rhombosortase, GlpG can cleave the GlyGly-CTERM domain and VesB engages 
with the T2S system for delivery to the extracellular milieu without going through 
a surface intermediate. The cleavage of VesB by GlpG is inefficient, however, 
and occurs only when rhombosortase is absent. Why VesB is preferentially 
cleaved by rhombosortase is not known; but it is possible that rhombosortase 
has a greater affinity than GlpG for VesB.  
 
Figure 3.9: Model. VesB is produced in the cytoplasm with an N-terminal signal 
peptide (blue) and a C-terminal GlyGly-CTERM domain (orange) (1). VesB is 
directed to the Sec machinery via the signal peptide. As the protein is pulled into 
the periplasm via the Sec system, the GlyGly-CTERM domain is positioned in the 
inner membrane (2). The signal peptide is cleaved off (3) and the protein folds 
(4). Rhombosortase (RssP) binds and cleaves the GlyGly-CTERM domain (5). 
The newly generated C-terminus of VesB is post-translationally modified to 
maintain VesB in the membrane (6). VesB is recognized by the T2S system and 
translocated through the outer membrane to the cell surface (7). The modified C-
terminus remains associated with the inner membrane or outer membrane thus 
preventing VesB from being released to the extracellular milieu. A fraction of 
surface-associated VesB is released through an additional processing event.  
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Initially, it was hypothesized that rhombosortase may cleave and thus 
release proteins from the cell (Haft & Varghese, 2011). We show here that 
although rhombosortase cleaves VesB, it also appears to promote its surface-
retention, and therefore, the rhombosortase/GlyGly-CTERM system can be 
compared to the sortase/LPXTG system of Gram-positive organisms and the 
archaeosortase/PGF-CTERM system of archaea. In all of these systems, 
substrates contain a C-terminal tripartite domain consisting of a recognition motif 
(GlyGly, LPXTG or PGF) followed by a hydrophobic region and positively 
charged residues (Abdul Halim et al, 2013; Schneewind et al, 1993). In 
Staphylococcus aureus, sortase cleaves staphylococcal protein A (SPA) a 
LPXTG substrate, between the Thr and Gly residues, resulting in an acyl-enzyme 
intermediate that is resolved by lipid II, a precursor of peptidoglycan (PG), 
instead of H2O (Marraffini et al, 2006). This results in PG-anchoring of SPA 
(Marraffini et al, 2006). While VesB may also undergo C-terminal 
transpeptidation rather than complete hydrolysis, the surface retained VesB is 
likely not attached to PG as it is of similar molecular weight as the surface 
released species, and if it were covalently attached to the PG it would not enter 
the separation gel when subjected to SDS-PAGE. VesB may, however, contain a 
short C-terminal lipid moiety that allows for membrane retention. The extraction 
of VesB from the cell envelope with Triton X-100 is supportive of this possibility 
(Figure 3.8). In the archaea system, archaeosortase appears to cleave or 
otherwise modify the PGF-CTERM domain of the S-layer glycoprotein. While it is 
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not known where archaeosortase cleaves or mediates transamidation to lipids, 
the S-layer glycoprotein is lipid modified at an unknown site (Abdul Halim et al, 
2013) and can be extracted using Triton X-100. Further studies will be done to 
elucidate the mechanism by which VesB is retained on the V. cholerae cell 
surface.  
Under some conditions, we observe more VesB in the supernatant than 
others (for example, in LB vs. M9 medium containing casamino acids and 
glucose; Figures 3.2 and 3.3). Further experiments will be done to determine 
exactly how VesB is released into the supernatant. Recently, cell wall attached 
sortase substrate SPA was found to be released into the culture supernatant by 
the removal of sugars from PG by LytN, a murine hydrolase, and polypeptide 
release by LytM, a pentaglycyl-endopeptidase (Becker et al, 2014). Additionally, 
in eukaryotes, glycosylphosphatidylinositol (GPI)-anchored proteins, like 
prostasin, can be released from the cell surface by lipid targeting enzymes like 
phospholipase C (Chen et al, 2001). VesB could similarly undergo an additional 
and perhaps regulated step of processing by another enzyme that allows it to be 
released from the cell just like SPA and prostasin. Proteomic analysis of WT 
culture supernatant suggests that release of VesB involves proteolysis.   
The dual locations of VesB pose an interesting question of why proteins 
have the GlyGly-CTERM extension for surface association only to have a portion 
of the proteins released to the extracellular space. While it is possible that the 
release of surface retained VesB only occurs under certain laboratory growth 
conditions, the release may be of physiological importance. VesB and other 
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GlyGly-CTERM proteins, which are mostly hydrolytic enzymes, may be of benefit 
to the individual bacterium when retained on the surface where they can break 
down macromolecules and generate nutrients for immediate cellular uptake. On 
the other hand, in the context of a biofilm, the released form of VesB and the 
other GlyGly-CTERM proteins could benefit the community of bacteria. While the 
role of VesB and other GlyGly-CTERM proteins has only recently received 
attention, inactivation of the vesB gene results in reduced fitness in V. cholerae 
intestinal colonization (Fu et al, 2013), VC1485 may be essential for growth 
(Chao et al, 2013) and deletion of the xds gene yields unstructured and compact 
biofilms and also a slight deficiency in cellular detachment from biofilm (Seper et 
al, 2011). Another GlyGly-CTERM protein, ExeM, has been shown to promote 
stable biofilm formation of the environmental species S. oneidensis (Godeke et 
al, 2011).  
In future studies, we will also investigate when and where the N-terminal 
propeptide is removed. Preliminary results suggest that VesB as well as VesC, 
another trypsin-like serine protease with a GlyGly-CTERM extension, may 
autoactivate once they are delivered to the cell surface. The lack of a surface 
intermediate for GlpG-cleaved VesB and VesB∆30 may explain why they are 
inactive (Figures 3.5 and 3.6). The means by which VesB and VesC are 
maintained as zymogens until they reach the exterior of the cell may be a built-in 
mechanism to prevent premature activation of these serine proteases while 
intracellular, thus avoiding uncontrolled proteolysis that could otherwise be 
harmful to the cells.  
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In summary, VesB has a novel GlyGly-CTERM domain and utilizes 
rhombosortase and the T2S system to be correctly processed, translocated 
across the cell envelope, and delivered to the cell surface of V. cholerae. The 
rhombosortase/GlyGly-CTERM system offers a new alternative method of 
surface association that differs from previously observed mechanisms. PnlH from 
D. dadantii possesses a non-cleavable TAT specific signal peptide that is needed 
for its outer membrane attachment (Ferrandez & Condemine, 2008), heat-labile 
enterotoxin from ETEC is retained on the cell surface via an interaction with 
lipopolysaccharides (Horstman & Kuehn, 2002) and the lipidated N-terminus of 
pullulanase keeps it surface-associated in K. oxytoca (Pugsley et al, 1986). 
Furthermore, the newly acquired knowledge of the GlyGly-CTERM domain of 
VesB provides insight to the previous findings of ExeM and Xds from S. 
oneidensis and V. cholerae, respectively. Both of these GlyGly-CTERM 
containing proteins are detected in culture supernatants; however, they are also 
cell-associated, and based on our findings, they are likely retained on the cell 
surface in a process that involves their GlyGly-CTERM domains and 
rhombosortase (Brown et al, 2010; Godeke et al, 2011; Newland et al, 1985; 
Seper et al, 2011; Tang et al, 2007). Consistent with our suggestion that GlyGly-
CTERM containing proteins are primarily localized to the cell surface, the four 
most abundant GlyGly-CTERM proteins, VesC, VC1485, VesB and VC0065, 
were recently detected in V. cholerae outer membrane vesicles by mass 
spectrometry (Altindis et al, 2014).  In conclusion, the rhombosortase/GlyGly-
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CTERM system presents a new sorting mechanism in V. cholerae and other 
Gram-negative bacteria.      
 
 
Materials and Methods: 
Bacterial strains and Plasmids:  
The V. cholerae El Tor O1 strain, N16961, and the isogenic Δeps (Sikora 
et al, 2007), ΔepsD (Sikora et al, 2009), ΔvesB, ΔvesAC, and ΔvesABC (Sikora 
et al, 2011) mutants were used in this study. All plasmids and primers are listed 
in Table 3.2. All polymerase chain reactions (PCR), cloning and restriction 
enzyme digestions were done with Phusion Polymerase, T4 DNA ligase and 
restriction enzymes from New England Biolabs and primers that were 
synthesized at IDT Technologies. pCRScript (Stratagene) and pMMB67EH 
constructs were transformed into E.coli MC1061 and pCVD442 constructs into 
SY327λpir. Triparental conjugation was performed with a helper strain, MM294 to 
transfer plasmids into N16961 and its isogenic mutants (Taylor et al, 1989).   
A kanamycin insertional rhombosortase mutant (rssP::kan) was created by 
amplifying the rhombosortase (rssP) gene (VC1981) from V. cholerae N16961 
chromosomal DNA using rssP primers. The fragment was ligated into a high 
copy plasmid, pCRscript. A kanamycin cassette was amplified from 
pK18mobsacB using kan primers containing BclI restriction enzyme sites and 
cloned into the native BclI site in rssP. The rssP::kan fragment was moved into 
the suicide plasmid, pCVD442. The rhomboid protease gene from V. cholerae, 
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glpG (VC0099) was deleted from the chromosome by amplifying 500 base pair 
regions upstream and downstream from glpG followed by overlap extension PCR 
of the two fragments to generate a 1.0 kbp fragment that was cloned into 
pCVD442.  
Table 3.2: List of primers and plasmids used. 
Gene or 
Plasmids Genotypes 
Forward Primer 5' 
to 3' 
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GATAGTTTACG SacI and SalI 
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 For complementation, rssP was amplified and cloned into pMMB67EH, a 
low copy vector with an IPTG inducible promoter and ampicillin cassette to 
generate pRssP. Using primers with base pair changes and the pRssP plasmid 
as template, fragments with rssP-S102A and rssP-H160A were made and cloned 
into pMMB67EH. vesBΔ5 and vesBΔ30 were amplified from pCRscript carrying 
vesB using newly created reverse primers with the forward primer originally used 
to clone vesB (Lybarger et al, 2009). PCR fragments were cloned into 
pMMB67EH. Quikchange Site Directed Mutagenesis Kit (Agilent) was used to 
create a mutation in pVesB to generate pVesB-S221A (Gadwal et al, 2014).  
 
Growth Conditions:  
Strains were either grown on Luria-Bertani (LB) agar/broth (Fisher) or M9 
media containing 0.4% glucose and 0.4% casamino acids with 100 µg/mL of 
carbenicillin (Sigma) when plasmids were present.  
 
Triton X-100 extraction:  
Cultures were centrifuged for 10 min at 16,000 ✕ g to separate culture 
supernatants and cells. Cell pellets were resuspended and treated with 
Tris/sucrose, EDTA, and lysozyme as described previously (Johnson et al, 
2007). Then, 10 µg/ml of DNase and 500 µl of 50 mM Tris-HCl pH 8.0 were 
added and the samples were sonicated using 30% amplitude for 10 sec with 1 
sec pulses. Lysed cells were centrifuged at 178,000 ✕ g for 1 hour at 4°C to 
separate the soluble fraction (containing periplasmic and cytoplasmic proteins) 
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from the membrane fraction. The membrane pellet was then resuspended in 
0.25% Triton X-100, 10 mM MgCl2 in 50 mM Tris-HCl pH 8.0, incubated on ice 
for 30 min, and then centrifuged at 178,000 ✕ g for 1 hour at 4°C. Following 
centrifugation, the supernatant contained the Triton X-100 extracted proteins. 
The pellet containing the Triton X-100 insoluble proteins was resuspended in 
0.25% Triton X-100, 10 mM MgCl2 in 50 mM Tris-HCl pH 8.0.  
 
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and 
immunoblotting:  
Samples were prepared and analyzed by SDS-PAGE and immunoblotting 
as described previously (Sikora et al, 2007). Polyclonal antiserum against VesB 
(Gadwal et al, 2014) was incubated with culture supernatant from the ΔvesABC 
mutant for 1 hour to pre-absorb cross-reactive antibodies prior to incubating with 
the nitrocellulose membrane for two hours (1:5,000). EpsL and OmpU (gift from 
K. Klose) antibodies were used at 1:20,000 and anti-GFP rabbit IgG (Molecular 
Probes) was used at 1:10,000 and incubated for two hours. Horseradish 
peroxidase-conjugated goat anti-rabbit immunoglobulin G (Bio-Rad) used at 
1:20,000 was incubated with the membrane for one hour. Membranes were 
developed using ECL 2 Western blotting reagent (Thermo Scientific) and 
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Protease Assay:  
V. cholerae supernatants and whole cells were measured for protease 
activity using N-tert-butoxycarbonyl-Gln-Ala-Arg-7-amido-4-methylcoumarin as 
described previously (Gadwal et al, 2014). A change in fluorescence per minute 
was calculated and converted to moles of methylcoumarin (AMC) cleaved per 
minute via a standard curve with known concentrations of AMC. The rate of AMC 
generation was normalized by OD600 of the cultures.  
 
Serine hydrolase Labeling:  
To 25 µl of filtered culture supernatants and washed cells, 0.5 µl of ActivX 
Serine Hydrolase Probe (Pierce) was added and incubated at room temperature 
for 30 minutes. Samples were visualized by SDS-PAGE and fluorescent imaging 
using the Typhoon imager system.   
 
Cell Labeling and Microscopy:  
Cells were washed, blocked with 2% BSA and incubated with 1:1000 of 
VesB antiserum that was pre-incubated with ΔvesABC cells to remove cross-
reactive antibodies. Following incubation with 1:1000 of Alexa Fluor 488 
F(ab′)2 goat anti-rabbit immunoglobulin G (Invitrogen) and washing, fluorescence 
was measured (Ex 495 nm/ Em 519 nm). These samples were also visualized by 
fluorescent microscopy using a Nikon Eclipse 90i fluorescence microscope 
equipped with a Nikon Plan Apo VC 100× (1.4 numerical aperture) oil immersion 
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objective and a CoolSNAPHQ2 digital camera as previously described (Lybarger 
et al, 2009).  
 
Proteomics/GeLC/MS Analysis:  
Culture supernatants of WT and rssP::kan strains were prepared as 
described with the following modifications (Johnson et al, 2013). Culture 
supernatants from three independent experiments were combined and 20µg of 
protein was processed by SDS-PAGE. The gel was stained with InstantBlue 
(Expedeon) and excised into ten equal sized segments using a grid pattern. Gel 
segments were digested with a ProGest robot (DigiLab) with the following 
protocol: washed with 25mM ammonium bicarbonate followed by acetonitrile, 
reduced with 10mM dithiothreitol at 60°C followed by alkylation with 50mM 
iodoacetamide at RT, digested with trypsin (Promega) at 37°C for 4h, quenched 
with formic acid, and the supernatant was analyzed directly without further 
processing. 
Each gel digest was analyzed by nano LC/MS/MS with a Waters 
NanoAcquity HPLC system interfaced to a ThermoFisher LTQ Orbitrap Velos 
Pro. Peptides were loaded on a trapping column and eluted over a 75µm 
analytical column at 350nL/min; both columns were packed with Jupiter Proteo 
resin (Phenomenex). The mass spectrometer was operated in data-dependent 
mode, with MS performed in the Orbitrap at 60,000 FWHM resolution and 
MS/MS performed in the LTQ. The fifteen most abundant ions were selected for 
MS/MS.  Data were searched using a local copy of Mascot with the following 
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parameters:  Enzyme: Trypsin; Database: Swissprot V. cholerae El Tor N16961 
(concatenated forward and reverse plus common contaminants); Fixed 
modifications: Carbamidomethyl (C); Variable modifications: Oxidation (M), 
Acetyl (N-term), Pyro-Glu (N-term Q), Deamidation (N,Q); Mass values: 
Monoisotopic; Peptide Mass Tolerance:  10 ppm; Fragment Mass Tolerance: 0.6 
Da; Max Missed Cleavages: 2. Mascot DAT files were parsed into the Scaffold 
algorithm for validation, filtering and to create a non-redundant list per sample. 
Data were filtered using protein and peptide thresholds of 99% and 95%, 
respectively, and requiring at least two unique peptides per protein.  The 
complete mass spectrometry proteomics data have been deposited to the 
ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org) via 
the PRIDE partner repository (Vizcaino et al, 2013) with the dataset identifier 
PXD000896. Data for the six GlyGly-CTERM proteins are shown in Table 3.1.  
 
Statistical Analysis:  
t tests were done on WT and mutant samples as indicated. Results 













 The goal of my dissertation work was to characterize the substrate 
specificity, as well as the catalytic triad and activation site of the protease domain 
of Vibrio cholerae extracellular serine protease B, VesB. Additionally, I sought to 
identify the roles of rhombosortase, the type II secretion (T2S) system, and the 
GlyGly-CTERM domain in surface localization of VesB. This chapter 
encapsulates key findings, the implications and future directions of my work. 
 
Function and Structure of VesB: 
 In chapter 2, I purified VesB from culture supernatants to determine 
substrate specificity with synthetic peptides and assess VesB’s ability to degrade 
intact proteins. VesB cleaves at arginine residues in synthetic peptides and is 
capable of cleaving proteins like casein, BSA, lactoferrin and IgA. Together, this 
suggests that VesB has a substrate specificity similar to trypsin and may be a 
general degradative enzyme that cleaves intact proteins. These findings indicate 
that a possible role of VesB is to provide nutrients for V. cholerae growth like 
other T2S substrates, HapA and ChiA
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(Connell et al, 1998; Halpern et al, 2003). However, in the small intestine 
nutrients are in excess, perhaps indicating that VesB may not be involved in 
nutrient acquisition but may instead have a specialized role in infection or 
colonization. Additionally, VesB could function in the context of a biofilm, where it 
may degrade proteins and provide nutrients to the biofilm. 
The role of Tyr250 in regulating VesB activity was investigated by 
measuring protease activity in the presence of increasing concentrations of NaCl. 
Despite the presence of this residue, Na+ did not enhance VesB activity but 
rather slightly reduced the activity, suggesting that VesB may function in both 
niches of V. cholerae, the human intestine and environmental reservoirs where 
the Na+ concentrations vary. In other experiments, we showed that the 
propeptide is removed in active VesB and mutagenesis of the activation site and 
the catalytic triad separately, led to undetectable VesB activity while the outer 
membrane translocation of VesB was unaffected. Taken together, these data 
suggest that the catalytic triad and removal of the propeptide are required for 
VesB activity.  
 The structure of an inactive VesB (VesB-S221A) without the GlyGly-
CTERM domain was determined by our colleagues Drs. Konstantin Korotkov and 
Wim Hol. The protease domain contains a trypsin-like fold that can be 
superimposed on trypsinogen. The C-terminal domain has an immunoglobulin 
(Ig)-fold composed of β-sheets and α-helices. The superposition of the C-
terminal domain of VesB on cucumisin and SfaE, two structural homologs, 
revealed that VesB contained two additional α-helices and β-sheets. The 
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significance of this finding is, at the moment, unknown. In chapter 2, I discuss the 
possible functions of the C-terminal Ig-fold domain in VesB. While the Ig-fold 
domain may convey stability, as VesB without the C-terminal domain cannot be 
detected (data not shown), it could also function as a T2S recognition signal. A 
role in substrate specificity is also a possibility, as the Ig-fold may confer higher 
affinity or specificity for a subset of substrates. We also proposed that the Ig-fold 
domain might be involved in cell surface binding. While the synthesis of a VesB 
variant without the GlyGly-CTERM domain is no longer cell associated (chapter 
3), suggesting a requirement for this domain in cell association, the Ig-fold 
domain may also contribute to cell surface binding. Taken together, VesB is a 
trypsin-like serine protease that cleaves a wide range of substrates and the 
modular domains of VesB contain a trypsinogen-like protease domain and a C-
terminal Ig-fold domain. 
     
The GlyGly-CTERM domain, rhombosortase, and the T2S system:  
 In chapter 2, I focused on secreted VesB. While VesB was originally 
identified as a T2S substrate (Sikora et al, 2011), a large portion of VesB was 
found associated with cells (chapter 3). Therefore, I focused on the cell-
associated form of VesB. VesB contains a C-terminal GlyGly-CTERM extension, 
which is composed of a stretch of glycines/serines, followed by hydrophobic and 
positively charged residues, therefore inferring that this domain possibly spans 
the cytoplasmic membrane (Haft & Varghese, 2011). Furthermore, in Gram-
negative bacteria that encode a single GlyGly-CTERM containing protein, next to 
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its gene, is a gene encoding rhombosortase, a rhomboid-like protease, 
suggesting a possible functional relationship between the two (Haft & Varghese, 
2011). In fact, rhomboid proteases are intramembrane serine proteases that are 
known to cleave single transmembrane domain proteins (Akiyama & Maegawa, 
2007; Strisovsky et al, 2009).  
My initial hypothesis was that VesB is cleaved at the GlyGly-CTERM 
domain by rhombosortase, thereby releasing it into the culture supernatant. 
However, in chapter 3 I showed that both the cell-associated and secreted forms 
of VesB have their GlyGly-CTERM domain removed. Furthermore, the cell-
associated form of VesB is surface-localized and active. To gain a better 
understanding of the cell surface VesB material, subcellular fractionation was 
conducted and the results showed that VesB is extracted with Triton X-100 in WT 
cells. This suggests that VesB may undergo lipid modification by rhombosortase 
or another enzyme, and this allows for surface retention through lipid-lipid 
interaction. Alternatively, VesB may be attached to the cell surface through a 
non-covalent interaction with a membrane protein, which is Triton X-100 
extractable. These findings led to the hypothesis that the GlyGly-CTERM domain 
and rhombosortase play a role in localizing VesB to the cell surface. The two 
pieces of evidence that support this are 1) when VesB is expressed without the 
GlyGly-CTERM domain, it is no longer cell-associated, and 2) in a 
rhombosortase mutant, native VesB is not detected in cell samples. In fact, in the 
latter case, the amount of VesB is reduced and only found in the culture 
supernatant due to rhomboid protease-mediated cleavage of VesB, suggesting 
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that rhombosortase may control the stability of VesB. Rhombosortase-mediated 
cleavage may result in the correct positioning of the C-terminal Ig-fold domain 
resulting in cell surface retention and/or stability of VesB. Taken together, 
chapter 3 demonstrates a novel sorting mechanism of Gram-negative bacteria, 
where the presence and subsequent removal of the GlyGly-CTERM domain of 
VesB by rhombosortase promotes cell surface retention possible through a lipid 
moeity.     
While studying rhombosortase, VesB and its GlyGly-CTERM domain in 
chapter 3, I made additional key discoveries related to the GlyGly-
CTERM/rhombosortase system. First, I discovered that cleavage of the GlyGly-
CTERM domain of VesB by rhomboid protease resulted in a phenotype different 
than cleavage by rhombosortase. When I focused on the C-terminal processing, I 
saw that VesB is cleaved by rhombosortase in WT, as well as T2S and rhomboid 
protease mutant cells. However, in the absence of rhombosortase, rhomboid 
protease cleaves VesB, which is then released to the culture supernatant. 
Additionally, when rhombosortase cleaves the C-terminus, VesB is active, while 
rhomboid protease-mediated cleavage results in inactive VesB. The reason for 
this lack of activity is due to the propeptide still remaining in rhomboid protease-
cleaved VesB. This unexpected, yet exciting finding led to the hypothesis that the 
activation of VesB occurs at the cell surface. In support of this, the fully secreted 
VesB variant without its GlyGly-CTERM domain has only a low, barely detectable 
activity.  
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Another key finding identified through this work is the ratio of VesB in 
culture supernatants and cells when grown under different conditions. In LB, 
overexpression of VesB leads to an even split of 50% of VesB present in the 
supernatant and 50% cell-associated. However, when grown in M9 media 
supplemented with casamino acids and glucose, overexpression of VesB leads 
to a majority of cell–associated VesB, with only a small amount released into the 
culture supernatant. While the ratio of VesB distribution differs, VesB is active 
under both conditions. The release of VesB from the cell surface may, therefore, 
have to do with an additional processing event that only occurs under certain 
growth conditions. Enzyme-mediated release has also been reported for cell 
surface anchored proteins in Gram-positive bacteria and GPI-anchored proteins 
in eukaryotes (Becker et al, 2014; Verghese et al, 2006). 
This chapter highlights the significance of the GlyGly-CTERM extension in 
VesB. Other proteins like Xds and ExeM that contain a GlyGly-CTERM domain 
have also been detected as extracellular and cell associated proteins (Brown et 
al, 2010; Godeke et al, 2011; Newland et al, 1985; Seper et al, 2011; Tang et al, 
2007). The exact role of the GlyGly-CTERM domain in these proteins was not 
investigated; however, proteomic analysis of V. cholerae culture supernatants 
showed that Xds is not detected in the absence of rhombosortase (Chapter 3). 
Therefore, the information learned from our studies of VesB can be extrapolated 
to these nucleases. Interestingly, Xds and ExeM were both shown to be involved 
in biofilm formation and maintenance (Godeke et al, 2011; Seper et al, 2011).  
This suggests that in addition to Xds and ExeM, VesB and other GlyGly-CTERM 
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domain containing enzymes may also be active in biofilms. It is possible that 
during planktonic growth, cell surface-retained VesB primarily benefits the 
individual cell by degrading substrates for immediate uptake of nutrients, while 
the released form of VesB may dominate during biofilm growth where it may be 
beneficial to the entire community. 
 
Working Model: 
Taking all of the experimental data and hypotheses together, I present a 
working model for the mechanism of VesB biogenesis, translocation, and 
function (Figure 4.1). VesB is made in the cytoplasm with its N-terminal signal 
peptide (blue) and propeptide (green), followed by the protease domain and C-
terminal domain (purple) with the GlyGly-CTERM extension (orange) (1). The 
protein enters the Sec system via the signal peptide and the GlyGly-CTERM 
domain may be placed into the inner membrane (2). The signal peptide is 
cleaved off (3) and the protein folds (4). Rhombosortase (RssP) cleaves the 
GlyGly-CTERM domain (4) and a post-translational modification like lipidation 
may occur (indicated by the blue asterisk) (5). VesB may stay linked to the inner 
membrane, and the β-sheet rich C-terminal domain of VesB may be recognized 
by the T2S system to gain entry (6). VesB translocates through the outer 
membrane (7) and is delivered to the cell surface, where it remains possibly 
linked by a lipid moiety (8). Once VesB is on the surface it may self-activate, 
leading to the removal of the propeptide (9). While the cell surface may be the 
final location of VesB, there are growth conditions where an additional 
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processing event either from a secreted or intracellular enzyme might lead to the 
release of VesB from the cell surface (9 and 10). Both the secreted and cell-
surface associated VesB are proteolytically active and may generate smaller 
peptides and/or amino acids that could be used to benefit the community of cells 
in a biofilm or be taken up immediately by the individual cell to use as nutrients.  
 
 Figure 4.1: Model for VesB biogenesis, translocation, and function.  
1. VesB is made in cytoplasm with a signal peptide (blue), propeptide (green), 
protease domain and C-terminal domain (purple) with the GlyGly-CTERM 
domain (orange). 2. VesB is translocated through the inner membrane by 
recognition of the signal peptide by the Sec system. The GlyGly-CTERM may be 
placed into the inner membrane. 3. The signal peptide is cleaved. 4. The protein 
folds and rhombosortase cleaves the GlyGly-CTERM domain. 5. Post-
translational modification, such as lipidation, may occur by rhombosortase or 
another enzyme. 6. The C-terminal domain of VesB may be recognized by the 
T2S system. 7. VesB enters the T2S system to be translocated through the outer 
membrane. 8. The lipid moiety might allow for cell surface-associated VesB. 9. 
VesB may self-activate and the propeptide is removed. 10. An additional 
processing event may occur under certain growth conditions to allow for release 
of VesB into the extracellular space. Both the extracellular and cell-associated 
forms of VesB may degrade substrates to be used in biofilms or by the individual 
cell. 
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Future Directions: 
While the new information here about the GlyGly-CTERM/rhombosortase 
system has contributed to the overall knowledge of proteins with the GlyGly-
CTERM sorting motif, additional questions remain to be answered. First, I want to 
identify the modification that occurs during processing of VesB by rhombosortase 
that is responsible for cell surface retention. In the LPXTG/sortase system, a 
nucleophilic attack by lipid II, a precursor of peptidoglycan, allows for covalent 
linking of the substrate to peptidoglycan (Marraffini et al, 2006). While we know 
that rhombosortase cleaves the GlyGly-CTERM domain, the nucleophile that 
resolves the acyl-enzyme VesB/rhombosortase intermediate remains to be 
elucidated. Because VesB is present on the cell surface and can be extracted 
with Triton X-100 like the archeal PGF-CTERM containing S-layer glycoprotein, 
which is lipid modified (Kandiba et al, 2013; Konrad & Eichler, 2002), this 
nucleophile may be a lipid. In Gram-negative bacteria, the inner and outer 
membranes are composed of proteins, lipoproteins, lipopolysaccharides (LPS) 
and phospholipids (Raetz et al, 2007). This leads to the hypothesis that the 
potential lipid moiety of VesB may originate from phospholipids or LPS in the V. 
cholerae cell envelope. Specifically, during synthesis of phospholipids or LPS, a 
precursor molecule may complete the nucleophilic attack, which would result in 
VesB being incorporated into either phospholipid or LPS.  
In E. coli and many other Gram-negative bacteria, the inner membrane is 
a phospholipid bilayer while the outer membrane is a heterologous bilayer 
consisting of phospholipids and LPS. Phospholipids are relatively small 
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molecules, weighing less than 1,000 Daltons and are composed of hydrophobic 
fatty acid chains linked to glycerol 3-phosphate and hydrophilic head groups. In 
bacteria, phosphatidylethanolamine (PE), phosphatidylglycerol (PG), and 
cardiolipin (CL) are the major phospholipids of the inner and outer membranes 
(Figure 4.2). Phosphatidylethanolamine (PE) contains ethanolamine as its head 
group and the amine can either be positively charged under low pH or uncharged 
under neutral pH (Cronan, 2003). LPS consists of a lipid A tail (~1,800 Daltons) 
and polysaccharides that contain the inner core, outer core, and the O-antigen. 
The lipid A tail makes up the outer leaflet of the outer membrane (Raetz et al, 
2007). In the El Tor strains of V. cholerae, lipid A of LPS contains either a glycine 
or diglycine that confers resistance to the antimicrobial peptide, polymyxin B 
(Hankins et al, 2012) (Figure 4.3). The glycine or diglycines are added onto the 
lipid A tail in a process involving three V. cholerae proteins, AlmG, F and E. 
Insertional mutants of almG, F and E synthesize LPS without the glycines and 
expression of this operon in a classical strain of V. cholerae, results in LPS with 
glycines (Hankins et al, 2012). Knowing this information, I propose that the 
molecule that resolves the acyl-enzyme VesB/rhombosortase intermediate, may 
be either the amine group of phosphatidylethanolamine or the glycine of lipid A in 
LPS. Because of the relatively small sizes of phospholipids and lipid A, the 
addition of either of these molecules would not significantly change the molecular 
weight of VesB. This is consistent with our findings, which showed that the 
surface-bound and extracellular forms of VesB migrate similarly when analyzed 
by SDS-PAGE.   
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Figure 4.2: The molecular structure of phospholipids in Gram-negative 
bacteria.  
The three major phospholipids of Gram-negative bacteria are cardiolipin, 
phosphatidyglycerol, and phosphatidylethanolamine. In general, all contain a 
hydrophobic fatty acid chain, which is then linked to glycerol 3-phosphate and the 





Figure 4.3: The structure of lipid A of lipopolysaccharides (LPS) from El Tor 
strains of V. cholerae.   
LPS is composed of a lipid A tail which makes up the outer leaflet of the outer 
membrane. The lipid A of V. cholerae contains either a single or double glycine 
(in red) attached to the hexa-acylated chain. Taken from (Hankins et al, 2012).  
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To test the first possibility that the nucleophile is the amine of 
phosphatidylethanolamine, I will take V. cholerae cells overexpressing VesB and 
treat them with commercially available phospholipases that target specific sites 
within the phospholipid molecule. After incubation, the supernatant and cells will 
be separated and analyzed by SDS-PAGE and immunoblotting to see whether 
VesB is released from cells. Several techniques will be used to determine if the 
nucleophile is the glycine of lipid A in LPS. In the El Tor biotype of V. cholerae, 
VesB is on the cell surface, however the location of VesB in the classical strains 
of V. cholerae, which lack the glycine(s) in lipid A (Hankins et al, 2012), is not 
known. Experiments will be done to determine the distribution of VesB in 
classical strains such as O395. If active VesB is not detected on the cell surface 
of O395, further studies will be done to determine if the glycines of lipid A are 
responsible for the nucleophilic attack. V. cholerae strains of the El Tor biotype 
lacking the almE-G genes will be constructed and the distribution of VesB will be 
determined by SDS-PAGE and immunoblotting as well as fluorescence 
microscopy (described in Chapter 3). If the glycine is not responsible for the 
nucleophilic attack, another component of lipid A could serve the same purpose. 
For example, in various Gram-negative bacteria, PmrC adds 
phosphoethanolamine to lipid A (Beceiro et al, 2011; Kim et al, 2006; Lee et al, 
2004), thus suggesting ethanlamine could complete the cleavage reaction by 
rhombosortase. In parallel experiments, VesB will be extracted from the cell 
surface, subjected to proteolysis using different enzymes and analyzed by mass 
spectrometry to determine the nature of the C-terminal modification.  
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In the case of GPI-anchored serine proteases, the C-terminal 
transmembrane domain is first cleaved off and then the newly generated C-
terminus is linked to ethanolamine of GPI by GPI transamidase (Antalis et al, 
2011; Chen et al, 2001). As discussed above, rhombosortase may act similarly to 
GPI transamidase. However, it is also possible that the cleavage and 
modification of VesB could happen by two different enzymes. A transposon 
mutagenesis screen will be constructed to identify the modifying enzyme.  
In chapter 3, I demonstrate that both the extracellular and surface 
attached VesB have their GlyGly-CTERM domain removed. The cell-associated 
form is retained on the surface possibly through a lipid modification. Therefore, I 
want to determine whether an additional cleavage step resulting in the removal of 
the modification allows for VesB to be released from the surface into the 
extracellular space. If the above experiments show that the modification is due to 
a lipid moiety, mutants of V. cholerae lacking phospholipases or lipases will be 
made and the distribution of VesB in the supernatant and cells will be observed 
via SDS-PAGE and immunoblotting. If a phospholipase or lipase is identified to 
process VesB and release it into the supernatant, studies will be done on the 
regulation of this protein under different growth conditions. Alternatively, if VesB 
is cleaved by rhombosortase and then modified by another enzyme, the 
regulation of this additional enzyme could be different in various growth 
conditions. This can give insight into the differences of VesB distribution when 
cells are grown in LB and M9 media.   
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Further experiments will be done to elucidate how rhomboid protease and 
rhombosortase function. The VesB experiments done in chapter 3 showed that 
C-terminal processing by rhomboid protease only happens in the absence of 
rhombosortase and results in secreted inactive VesB, whereas rhombosortase-
mediated cleavage results in cell-associated active VesB. The functional 
differences of these two enzymes may be due to structural differences. First, 
rhomboid protease contains an additional N-terminal cytoplasmic domain that 
may affect the mechanism by which it processes substrates. Second, although 
rhombosortase appears to display the same membrane topology as rhomboid 
protease, the composition of their active sites and surrounding areas may differ. 
One way to address the diference in activity of these proteases is to swap helices 
of both proteins or add the N-terminal domain of rhomboid protease to 
rhombosortase and observe the activity and distribution of VesB. 
The experiments in chapter 3 suggest that rhombosortase cleaves the 
GlyGly-CTERM domain whether the T2S system is present or not, suggesting 
that removal of the GlyGly-CTERM domain precedes outer membrane 
translocation. Furthermore, subcellular fractionation shows that VesB may enter 
the T2S system through an inner membrane intermediate similar to PulA, the 
lipoprotein from Klebsiella oxytoca (Pugsley & Kornacker, 1991; Pugsley et al, 
1990) rather than a periplasmic intermediate. It is believed that T2S substrates 
enter the T2S system via EpsD and/or EpsC whether they are soluble 
periplasmic intermediates or tethered to the inner or outer membrane (Korotkov 
et al, 2012). Further studies will be done to elucidate the mechanism of how lipid-
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modified VesB enters the T2S system from the inner membrane position. This 
may however be difficult if the entry is rapid. Lipoproteins and other molecules 
that have fatty acid chains are moved throughout the cell with the help of proteins 
that protect the lipid moieties (Okuda & Tokuda, 2011; Raetz et al, 2007). VesB 
may move through the T2S system with its lipid modification protected. Further 
studies will be done to identify if a component of the T2S system or VesB itself 
may protect the lipid moiety. 
  
Conclusions:  
The work presented here is the first to demonstrate the substrate 
specificity, structure, and importance of the catalytic triad and activation site for a 
bacterial two-modular trypsin-like serine protease. Apart from the extensively 
studied LPXTG/sortase of Gram-positive bacteria and the lesser-known PGF-
CTERM/archeosortase systems, the GlyGly-CTERM/rhombosortase system, with 
the assistance of T2S, is a newly described sorting mechanism of cell-surface 
proteins in Gram-negative bacteria. The information on the sorting mechanism of 
VesB is applicable to other GlyGly-CTERM containing proteases like Xds and 
ExeM that have been shown to play a role in biofilms (Godeke et al, 2011; Seper 
et al, 2011). Biofilms are important to maintain the survival of bacteria in host 
organisms or environmental reservoirs, thus imposing a threat to human health. 
Therefore, the GlyGly-CTERM/rhombosortase system presents a novel target for 
therapeutics to prevent disease. 
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